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An injured vascular system has a substantial impact on an individual’s overall 
health, and an understanding of the mechanisms that underlie blood vessel 
pathophysiology is required for the development of rational and effective treatment 
strategies.  The phenotypic modulation of smooth muscle cells (SMC) during vascular 
injury, characterized by altered adhesion, migration and synthetic behavior, plays an 
important role in the eventual outcome.  Specifically, the ability of SMCs to adhere to 
and remodel their extracellular environment via regulation of the syndecan class of cell 
adhesion molecules dictates the response of the vascular wall to local injury.  The effect 
of in vitro syndecan-4 regulation on SMC adhesion was investigated through the use of a 
glass microsphere centrifugation assay, and an antisense-mediated reduction in gene 
expression was found to correlate with decreased adhesive strength.  Regulation of 
syndecan-1, syndecan-2, and syndecan-4 gene expression was observed experimentally 
by mechanical strain of SMCs.  Using real-time polymerase chain reaction (PCR), the 
kinetics of both static and cyclic mechanical strain were found to modify the gene 
expression in a time and strain magnitude-dependent manner unique to each syndecan.  In 
particular, the responses of syndecan-4 were acute, but transient, while the evolution of 
syndecan-1 and syndecan-2 regulation was delayed by comparison.  Mechanical strain 
also modulated syndecan-4 protein expression and ectodomain shedding, as measured by 
Western immunoblotting, and this effect was found, through selective inhibition, to be at 
least in part dependent on mitogen-activated protein (MAP) kinase signaling.  In 
particular, intact extracellular signal-regulated MAP kinase (ERK) 1/2 and c-Jun NH2-
 xxii
terminal kinase / stress-activated protein kinase (JNK/SAPK) signaling pathways were 
found to be required for the observed strain-induced shedding.  These findings offer a 
better understanding of syndecan function in response to mechanical strain and suggest 
potential new mechanisms by which physical forces may modulate vascular SMC 
behavior and regulation during normal physiology, pathologic conditions, and engineered 





1.1 Specific Aims 
Coordinated changes in smooth muscle cell (SMC) adhesion and migration are 
fundamental methods of vascular wall adaptation to many forms of physiologic and 
pathologic stress.  While a variety of molecular events underlie these cellular responses, 
cell surface heparan sulfate proteoglycans (HSPG) are especially important through their 
interactions with heparin-binding molecules that either reside permanently or appear 
transiently in and near the vascular wall.  Recent evidence implicates the HSPG 
syndecan-4 as having a significant role in influencing vascular mesenchymal cell 
adhesion and migratory behavior that is associated with matrix reorganization2-4.  This 
reorganization is primarily due to interactions with extracellular matrix (ECM) proteins. 
The central hypothesis of the work described in this manuscript is that syndecan-4 
expression and shedding is regulated by the local cellular mechanical environment.  
Secondly, these strain-induced alterations in syndecan-4 gene and protein expression are 
controlled by a mitogen-activated protein (MAP) kinase signal transduction cascade.  We 
postulate that, through the regulation of these and other key intracellular signaling events, 
mechanical strain modulates cell surface syndecan-4 levels, and thereby alters cell-ECM 
adhesive interactions.  Overall, this results in a paradigm for mechanical strain-induced 
regulation of vascular remodeling.  This work is motivated by (1) investigations by us 
and others demonstrating the important role of cell surface HSPGs in cell adhesion and 
migration and (2) the capacity of both cell surface and shed syndecans to bind a variety of 
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growth and pro-inflammatory factors that can modulate a range of physiologic and 
disease-related responses in the vascular wall. 
We believe that syndecan-4 plays a critical role in vascular biology through its 
interaction with ECM ligands; however, due in part to its relative non-specificity, 
elucidation of its diverse functions has historically proven to be a complex task.  
Nonetheless, there is clear evidence for its role in key elements of vessel injury response 
and remodeling.  The Specific Aims of the project were (1) to investigate the manner in 
which mechanical stimuli regulate cell surface syndecan-4 in vascular SMCs, (2) to 
characterize the signaling mechanisms that are involved in strain-mediated changes in the 
expression and shedding of syndecan-4, and (3) to determine the extent to which 
regulation of syndecan-4 influences the strength of cell-substrate interactions during late 
phases of the adhesion process. 
To accomplish our experimental objectives, the methodology presented in this 
dissertation utilized in vitro vascular SMCs as a model system.  Well-characterized 
techniques were used to apply mechanical strain to the cells and to quantify the adhesive 
interaction between them and the ECM.  Investigations were aimed at analyzing various 
levels of syndecan-4 regulation, allowing us to examine its influence in vascular SMC 
and ECM adhesive interactions.  In select instances, syndecan-4 responses were 
compared to those of other syndecan family members expressed in SMCs, including 
syndecan-1 and syndecan-2.  The following approaches were taken: 
 
1.1.1 Investigation of  the manner in which mechanical stimuli regulate cell surface 
syndecan-4 in vascular SMCs 
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Human aortic SMCs grown on flexible silicone membranes were used to define 
the ability of mechanical stimuli to ultimately influence cell surface syndecan-4 
regulation.  This involved determining gene and protein expression patterns, as well as 
ectodomain shedding.  Additionally, comparative analyses to syndecan-1 and syndecan-2 
were performed.  To accomplish this we subjected the cells to clearly-defined strain 
protocols as in vitro models of relevant physiological events.  We then examined the 
subsequent regulation of syndecan expression in order to evaluate the effect of these 
stimuli on that regulation. 
 
1.1.2 Characterization of the signaling mechanisms involved in strain-mediated 
changes in the expression and shedding of syndecan-4 
The extent and timescale in which mediators of mechanical strain-induced 
syndecan-4 protein expression and regulation occur were evaluated.  In particular, we 
focused on the MAP kinase signal transduction pathways as potential mediators of this 
response, and made use of chemical and peptide inhibitors of specific enzymes required 
by these pathways.  Our studies served to implicate multiple signaling pathways involved 
in syndecan-4 expression and shedding, and provided potential future targets for 
manipulation of these events. 
 
1.1.3 Determination of the extent to which syndecan-4 regulation influences the 
strength of cell-substrate interactions during late phases of the adhesion process 
Adhesive interactions between rat pulmonary artery SMCs and fibronectin-coated 
glass microspheres were characterized using a modified centrifugation methodology.  By 
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employing the ability of this assay to exert the necessary detachment forces to a cell 
monolayer, we were able to determine how syndecan-4 modulates adhesion between the 




According to the Heart Disease and Stroke Statistics published by the American 
Heart Association, cardiovascular disease remains the primary cause of mortality in both 
women and men in the United States5.  More than 945,000 cardiovascular-related deaths 
occurred in 2001 at a cost of greater than $350 billion in health expenditures and lost 
productivity.  It claimed more lives than the next 5 leading causes of death combined.  In 
particular, peripheral vascular disease affects 8 to 12 million Americans.  The total 
number of surgical and non-surgical procedures has risen from 4.3 million in 1998 to 
over 5.9 million in 2001, and in the past 20 years, the number of cardiac catheterizations 
has increased 341 percent6,7. 
While these interventions consist of a variety of procedures, including balloon 
angioplasty, endarterectomy, and artificial bypass grafting, all involve some form of 
acute mechanical injury to the vascular wall, which in turn initiates a sequence of 
physiologic events necessary for lesion repair.  Likewise, as a form of chronic 
mechanical injury, hypertension can also initiate events that contribute to changes in the 
structure of the vessel wall, leading to increased susceptibility to atherosclerosis, 
aneurysm formation, and plaque disruption8,9.  Significantly, recent evidence in the field 
of cardiovascular bioengineering has uncovered an important role for mechanical 
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stimulation in the development of a robust tissue-engineered blood vessel10-15.  Thus, 
restenosis after acute local injury, hypertension-induced remodeling, and the tissue 
engineering of an arterial substitute through mechanical conditioning in a bioreactor are 
examples of processes in which cells alter tissue architecture in a manner that is 
influenced, in part, by their responses to changes in their local biomechanical 
environment. 
 
1.2.2 Vascular Wall Mechanics 
The uniquely complex environment of the vascular system is largely due to its 
dynamic chemical and mechanical environment.  In addition to the transport-related 
consequences of unsteady flow of a non-Newtonian fluid, the cells which comprise the 
blood vessels are subject cyclic and non-uniform stresses16.  If the artery were a classic 
pressure vessel, governed by LaPlace’s and Hooke’s laws, a fairly simple relationship 
between transmural blood pressure and wall stretch would exist: 
 
 
Figure 1. Simplified view of vascular hemodynamics.  The drawing above represents 
an artery, bisected along its longitudinal axis.  If modeled as an open-ended, thin-walled 
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where θε  is circumferential strain; θσ is circumferential (hoop) stress; P is transmural 
pressure; R is vessel radius; h is wall thickness; E is Young’s modulus.  Although this 
equation is only applicable for infinitesimal strains of a thin-walled, linear elastic 
cylinder, it demonstrates the general effect of local hemodynamics and vessel geometry 
on the state of stress in the vascular wall.  The force that actually causes the vessel wall to 
expand causes an outwardly directed radial stress, which can be completely described in 
terms of circumferential deformation.  In other words, a given mean arterial pressure 
results in a certain level of stress in the wall, and the actual strain depends on the modulus, 
or wall stiffness.  The circumferential stress is mediated by intercellular connections, and 
it is a result of the production of longitudinal forces between cells during vasomotion17.  
Despite this description, the dynamic interaction between blood flow, blood pressure, and 
wall mechanics in the native artery is neither simple nor straightforward. 
The vascular wall exhibits complex material properties, including nonlinearity, 
spatial heterogeneity, anisotropy, and viscoelasticity.  In addition, the presence of 
residual axial and circumferential stresses, perivascular tethering, and basal muscular 
tone make it difficult to analyze and theoretically model.  Moreover, the properties of the 
vessel wall vary along the vascular tree.  Large and medium-sized arteries behave 
differently than capillary vessels, which in turn behave differently than low pressure 
veins.  Nevertheless, several simplifying assumptions can still be employed and have 
been shown by others to allow for reasonably accurate estimation of the local physiologic 
stresses and strains, i.e. the micromechanical environment, experienced by the individual 
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cells in the vessel wall (reviewed by Humphrey)18.  First, the geometric symmetry of the 
vessel allows it to be considered as cylindrically orthotropic19.  Studies have also shown 
that principal stresses exist mainly in the circumferential (tensile) and radial 
(compressive) directions.  Additionally, due in part to the presence of residual stress, 
mechanical function follows histological form, as the artery can be considered to be 
composed of two separate, homogeneous layers – media and adventitia, resulting in 
constant stress distribution in each layer20-24.  
In addition to the stresses of normal hemodynamics, cells in the vascular wall are 
subjected to abnormal stresses due to pathologic states, as well as acute injury during 
clinical interventions.  When transmural blood pressure is chronically elevated, the 
mechanical environment becomes the primary determinant of both intimal hyperplasia 
and medial thickening.  Since stresses are functions of the vessel wall geometry, a 
mechanism naturally exists by which the affected cells can counterbalance hydrodynamic 
effects by initiating responses that may ultimately change lumen diameter, wall thickness, 
and compliance.  This occurs primarily through cell proliferation, apoptosis, migration, 
and remodeling of the ECM.  Similarly, one of the most commonly induced injuries 
occurs as a result of balloon catheterization, in which acute vessel expansion is 
accomplished by direct compression of the wall constituents.  Despite its therapeutic 
benefits, angioplasty results in endothelial denudation, fracture and dissection of 
atherosclerotic plaque, overstretch of the non-diseased wall, and extrusion of fluid from 
the lesion25-27.  Accordingly, this type of injury elicits a subsequent cellular reaction, 
leading to a characteristic wound healing and remodeling response.  On a cellular level, 
there exists a coordinated process of SMC and fibroblast differentiation, adhesion, and 
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migration, while on a molecular level, cell surface and soluble proteins are regulated both 
spatially and temporally.  If these events are deficient, the vessel wall, in principle, can 
become weakened and may be susceptible to aneurysmal degeneration.  More commonly 
however, these responses are overactive; and in turn, scar formation and restenosis occur, 
as is often the case following vascular graft implantation or angioplasty, with the 
potential for failure of the clinical intervention. 
 
1.2.3 The Extracellular Matrix and Remodeling 
Many living tissues change their mass, metabolism, and deposition / re-uptake of 
ECM proteins in response to changes in mechanical stress28.  Matrix remodeling is a 
process common to many reparative vascular events, including post-angioplasty 
restenosis, transplant vasculopathy, and the outward remodeling that occurs in 
conjunction with a developing atherosclerotic plaque29.  It is the term given to the process 
of synthesis, degradation, and rearrangement of ECM components to maintain 
homeostasis, and it involves both transient and permanent changes in tissue architecture, 
such as basement membranes, basal laminae, and interstitial stroma30.  In fact, the ECM 
has been described as “homeostatic” due to the tight regulation of its components and the 
influence this action has on mesenchymal cell behavior29,31.  This behavior is determined 
by a combination of interactions with both other cells and the ECM.  The ECM is 
composed of fibrillar and non-fibrillar constituents, including collagen, elastin, 
glycoproteins such as fibronectin and laminin, and proteoglycans such as perlecan and 
versican1,32,33.  The composition of this matrix has a profound impact on the type of 
cellular interactions that take place.  It also determines the tensile strength and resilience 
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of the tissue.  Mesenchymal cells, for their part, interact with each other through the 
association with their local ECM.  For example, they bind matrix proteins, secrete growth 
factors, and release cytokines and proteases, thereby altering the surrounding chemical, 
and remodeling the surrounding mechanical, environment. 
Such vascular wall remodeling is a critical event in the pathophysiology of 
atherogenesis, restenosis, and in the development of a tissue-engineered vascular graft34-
37.  When a tissue is induced to undergo any type of structural change, it does so largely 
through a rearrangement of its ECM composition.  While it is clear that in many cases the 
events are adaptive in nature and serve to counterbalance injury, in other cases these 
events are either inadequate or lead to undesirable conditions.  For example, 
compensatory dilation under the influence of prolonged hypertension can result in 
aneurysm formation.  Ultimately, the role of the cellular components is to maintain a 
functional balance.   
Of particular interest in cardiovascular bioengineering is the occurrence of this 
balancing act during wound repair and tissue engineering.  Both require extensive 
remodeling events, including provisional matrix deposition, tissue or wound contracture, 
and eventual re-epithelialization; these events also involve cell activation, adhesion and 
migration.  Glagov et al., who introduced the concept of compensatory remodeling in the 
coronary arteries, demonstrated that this process allows the lumen area to remain constant 
as atherosclerotic disease progresses38.  The accepted reason for this is that the total 
vessel diameter increases to compensate for the lumen encroachment.  Controlled 
remodeling events hold particular significance in the tissue engineering of an arterial 
substitute, which typically includes re-population and organization of appropriate cellular 
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components, matrix deposition, and tissue contracture.  Regardless of the specific 
stimulus or response, a model for vascular remodeling includes four generalized events: 
(1) recognition of changes in either the ECM, the flow environment, or mechanical 
properties of the arterial wall; (2) intracellular transduction of these signals and 
communication to adjacent and nearby cells; (3) expression and release of paracrine 
mediators which alter cellular activity; and (4) resultant structural changes in the vessel 
wall39-41.  Therefore, in this model the ultimate effectors of specific vascular remodeling 
events are the resident cells in direct physical proximity to the responsible stimulus. 
 
1.2.4 Cellular Basis for Vascular Remodeling 
Among the cellular components in the vessel wall, a great deal of work has been 
aimed at elucidating the role of the endothelium17,42-44.  Its role in sensing shear stress, 
mechanical stretch, and the chemical composition of the blood, using a variety of 
specialized receptor mechanisms, as well as its transduction of these signals, has 
underscored its importance in vascular biology.  However, the role of the underlying 
medial and adventitial mesenchymal constituents is considerably less well characterized. 
Two classes of mesenchymal cells are of particular interest with respect to 
vascular wall remodeling.   In the vascular wall, these cells include SMCs and adventitial 
fibroblasts.  In response to injury, SMCs undergo a change from a quiescent and 
contractile to a synthetic phenotype.  This is followed by migration into the sub-
endothelial neointima, where these cells synthesize, deposit, and organize ECM 
components.  These cells are the primary sources of collagens, elastic fibers, and 
proteoglycans35,45. 
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Arterial injury also appears to induce the proliferation and transmigration of 
myofibroblasts into the sub-endothelium, which may in turn lead to lumenal stenosis46-49.  
Myofibroblasts are derived from fibroblasts that have become activated, and are 
identified most commonly by their expression of α-smooth muscle actin.  Originating in 
the adventitia, they also deposit collagen, as well as migrate into the neointima.  
Migrating cells produce ECM-degrading enzymes and plasminogen activators to 
facilitate their movement, similar to the fibroblasts that degrade connective tissue in the 
dermis after skin damage50-52.  Just as this cellular activity alters the extracellular 
environment, cell proliferation, differentiation, adhesion, migration, and changes in shape 
are in turn dictated in part by the ECM.  Evidence is accumulating that the cells are 
exquisitely sensitive to the composition of their local microenvironment53,54.  For 
example, Koyama et al. suggest that a polymerized collagen substrate alters cyclin-
dependent kinase 2-dependent cell cycle progression through regulation of integrin 
signaling55.  Ichii et al. have also demonstrated that polymerized collagen suppresses a 
number of genes associated with integrin-dependent migration of SMCs56.  The 
sensitivity of cells to their microenvironment is primarily dictated by the cell surface 
receptors which, among others, include integrins and syndecans. 
 
1.2.5 Syndecan Structure and Function 
A widespread and evolutionarily conserved class of molecules that resides on the 
surface of all animal cells includes the HSPGs, which consist of two minor and two major 
families.  The minor HSPGs – betaglycan and CD44 – contain heparan sulfate (HS) 
chains only under certain conditions.  On the other hand, the major HSPGs – glypicans 
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and syndecans – always have covalently attached HS chains1.  The glypicans are 
anchored to the plasma membrane via a glycosylphosphatidyl inositol (GPI) linkage, 
whereas the syndecans are type I transmembrane proteins. 
It has been proposed that the main function of syndecans is to modulate ligand-
dependent activation of integrin receptors at the cell surface57.  Recent evidence, however, 
has shown that this view is incomplete.  Syndecans, first described by Sanderson and 
Bernfield58, have been shown to function in capacities ranging from growth factor and 
cytokine cell surface localization and binding59,60 to intracellular signaling complex 
assembly, and they appropriately have their roots in the Greek word syndein, meaning “to 
bind together”61.  In addition, studies have even demonstrated a role in nuclear 
transcriptional activity62. 
The various functions of the syndecan family members are undoubtedly governed 
by their individual structures, and despite the fact that each syndecan has a slightly 
different role in cellular function , the syndecans can be considered as two subfamilies1.  
Syndecan-1 (CD138) and syndecan-3 (N-syndecan) represent one subfamily, while 
syndecan-2 (fibroglycan) and syndecan-4 (ryudocan, amphiglycan) represent the other.  
All four syndecans share some common general features (see Figure 2A).  They are 
HSPGs, and therefore consist of a core protein decorated with pendant, disaccharide-
laden glycosaminoglycan (GAG) chains.  The core protein consists of a short, highly 
conserved cytoplasmic domain, a single-pass transmembrane domain, and a variable 
ectodomain.  The cytoplasmic domain is composed of two invariant (C1 and C2) domains 
and one variable (V) domain, and contains regions for phosphorylation, binding of cell 
scaffolding proteins, and interaction with the actin cytoskeleton.  The transmembrane 
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domain aids in syndecan oligomerization, and localizes syndecans within discrete 
aggregates in the membrane, such as focal adhesions63-65.  The ectodomains contain 
regions for attachment of GAG chains, which are typically HS and chondroitin sulfate 
















Figure 2. Syndecan core protein (A) and heparan sulfate structure (B). 
 
 





















The differences between the syndecans lie in some key specifics.  Structurally, the 
V region of the cytoplasmic domain and a majority of the ectodomain vary for each 
family member.  For example, an adhesion site has been demonstrated within the 
syndecan-4 ectodomain only66,67, and unlike the other family members, it has a high 
affinity for membrane phospholipids.  In addition, the ectodomains are variable in length.  
While all syndecans have GAG attachment sites near the N-terminus which typically bind 
HS, syndecan-1 and syndecan-3 also have sites near the plasma membrane for CS 
binding.  The distribution of each syndecan is also unique.  Syndecan-1 is expressed early 
during embryonic development, as well as in epithelia, mesenchymal tissue, and B cells 
of the immune system.  Syndecan-3 is expressed in neuronal and musculoskeletal tissues.  
Syndecan-2 is distributed in neuronal cells as well, but also in mesenchymal and hepatic 
tissue.  Lastly, syndecan-4 has been detected in a wide variety of cell types65,68.  As a 
result of these variations in developmental and tissue distribution, the family of 
syndecans enables cells to interact in numerous capacities throughout the body. 
The physiologic activity of many proteins depends on or is enhanced by 
interactions with heparan sulfates69.  For example, syndecan ectodomain shedding is 
important in sequestering soluble ligands and reducing the number of remaining available 
cell surface receptors70,71.  Also, heparan sulfates serve as a means in which several 
microbial pathogens can gain entry into host cells65.  Additionally, shed syndecan-1 
ectodomains have been implicated in regulating the proteolytic activity of acute wound 
fluid72.  The objective of this thesis was to demonstrate that certain functions of 
syndecans may play a role in strain-mediated responses of the vascular wall. 
Given the evidence for HSPG interactions with numerous matrix proteins73-75, and 
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assembly into focal adhesions63,76-79, our lab has sought to determine the role of small 
heparin-binding peptides in cell adhesion phenomena in vitro, and we have demonstrated 
that soluble peptides interfere with syndecan-ECM interactions, and thereby reduce cell-
substrate adhesive strength80,81.  In our previous work, PAC-1 immortalized rat 
pulmonary artery cells were treated with heparin-binding peptides derived from 
fibronectin or von Willebrand Factor (vWF), and our results demonstrated that these 
oligopeptides reduced the relative centrifugal force (RCF) corresponding to 50% cell 
detachment (RCF50), a quantitative measure of cell-substrate adhesion, in a dose-
dependent manner.  We have also demonstrated in an in vivo model that syndecan-4 gene 
and protein expression were regulated in a temporally and spatially specific manner after 
balloon injury of the rat carotid artery82.  Furthermore, ongoing research in our lab is also 
investigating the association between atherosclerosis and syndecan localization within the 
vascular wall in vivo. 
 
1.3 Significance 
Our interest in the role of syndecan-4 in adhesion and vascular remodeling is 
motivated by the results of previous workers in the field.  Specifically, the work of 
Bernfield, Tumova, Couchman, and others have recently described roles of HSPGs in cell 
adhesion and migration1-3,76,83-86.  Likewise, Horowitz, Oh, and others have elucidated 
many of the mechanisms in which HSPGs regulate intracellular signaling75,87-93.  
Improvements in the quantitative techniques for analyzing single cell94,95 and population-
based81,96-98 adhesion to the extracellular matrix has allowed for the appreciation of subtle 
differences in discrete stages of the adhesion process.  Efforts geared toward thwarting 
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the remodeling behavior of SMCs in vivo or enhancing that same behavior during 




REGULATION OF SYNDECAN-4 HAS IMPLICATIONS ON CELL-
SUBSTRATE ADHESIVE INTERACTIONS 
 
Cell-matrix adhesions, typically characterized as physical links between the 
extracellular matrix and internal actin cytoskeleton, are necessary for both the movement 
of cells and the generation of traction forces that effect matrix remodeling.  In particular, 
focal adhesions, involving actin, α-actinin, talin, vinculin, paxillin, and tensin were 
originally described as regions of close contact (10-15 nm)99,100.  They are thought to 
represent a general form of interaction between cytoskeletal proteins, integrins and other 
adhesion receptors, and the substratum.  It has recently become clear that regulation of 
focal adhesion formation, and the interaction of adhesion receptors with the actin 
cytoskeleton via intracellular scaffolding proteins, are critical to the control of cell 
migration.  Our aim was to employ a glass microsphere centrifugation assay, which is a 
modified form of the commonly used centrifugal detachment assay, to quantify cell-ECM 
adhesive interactions.  Using an antisense-containing adenoviral vector to down-regulate 
specific protein translational activity, we then assessed the functional role of syndecan-4 
on these interactions.  We postulated that this modulation of syndecan-4 would lead to 
decreased adhesive forces.  
 
2.1 Background and Significance 
2.1.1 Biological Importance of Cell Adhesion 
Cellular adhesive interactions are crucial to the proper functioning of cells, tissues 
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and organisms.  From embryonic cell migration in the developing fetus to leukocyte 
rolling and margination in the cellular defense against infection, intercellular and cell-
ECM adhesive interactions help to guide cell movement and direct cell function.  In 
addition to its part in normal physiology, cell adhesion plays a role in many pathologic 
conditions, including tumor metastasis101 and atherosclerosis102. 
Current knowledge recognizes integrin-ligand binding as the principal means of 
cell-ECM adhesion103,104.  Through their interaction with the actin cytoskeleton and the 
recruitment of cytoplasmic proteins into focal adhesion complexes, integrins play a 
critical role in the cell’s interaction with its extracellular environment.  Despite this fact, 
other cell adhesion molecules, including cadherins, selectins, and the immunoglobulin 
superfamily class of receptors, play important roles in cellular interactions with other 
cells and with their environment, and only fairly recently has the ubiquitous and 
evolutionarily conserved syndecan family of HSPGs received adequate recognition for its 
role in cell-ECM interactions. 
 
2.1.2 Syndecan-4 and Adhesion 
As a result of their structure, HSPGs, including syndecan-4, interact with the 
heparin-binding sites of a number of small peptides and macromolecules.  These include 
fibronectin (FN), interstitial collagens, antithrombin III, epidermal growth factors, 
microbial peptides, chemokines, and lipoprotein lipase, among others1.  Recent evidence 
supporting the hypothesis that syndecan-4 is an important regulator of cell adhesion 
includes work by Couchman and others.  Cell surface heparan sulfates have been shown 
to be necessary for the development of focal contacts105 due to the intracellular signaling 
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that follows the interaction between surface HSPGs and their ligands.  Studies have 
demonstrated syndecan-4 localization to focal adhesions in several cell types, in which 
this proteoglycan helps direct focal adhesion assembly63,77,78,84.  Also, syndecan-4 
overexpression in Chinese hamster ovary (CHO) cells leads to increased focal adhesion 
assembly, while truncation of the cytoplasmic V region leads to reduced cell spreading 
and focal adhesion formation3. 
In this regard, syndecan-4 has been shown to co-localize with β1 and β3 integrins 
within focal adhesions3,63,76, and although syndecan-4 may not always be necessary for 
focal contact formation106, it does appear to play a key role in cell adhesion, as well as 
cell spreading, clustering of adhesion receptors, and stress fiber formation.  Notably, 
syndecan-4 has recently been shown to directly mediate the β1-integrin-dependent 
binding, spreading, and focal adhesion formation to the cystein-rich domain of a 
disintegrin and metalloprotease (ADAM) 1283,107.  Additionally, syndecan-4 has been 
associated with important signal transduction cascades, such as activation of protein 
kinase C (PKC), that underlie many of these cellular events75,91.  For example, upon cell 
binding to fibronectin via α5β1 integrins108, syndecan-4 molecules accumulate, possibly 
due to adjacent GAG-binding domains on the FN monomer109,110 and oligomerize via 
their cytoplasmic domains, leading to the formation of focal adhesions77,105.  Thus, as a 
co-receptor for both soluble and insoluble ligands, and through organization of 
subplasmalemmal scaffolding proteins, including vinculin and α-actinin, syndecan-4 can 
induce changes in actin cytoskeletal organization57,111-113.   For these reasons, the 
syndecan-4 core protein and their highly sulfated pendant chains were the targets of our 
experimental strategy.   
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Atherosclerotic lesions occur when SMCs migrate toward the lumen, proliferate, 
and secrete ECM components, including collagen, fibrin and proteoglycans.  The 
plasticity of SMC phenotype allows for them to become synthetic during remodeling in 
response to changing hemodynamic conditions; however, this is often undesirable during 
the development of an atherosclerotic lesion and post-angioplasty restenosis114.  Taken 
together, the experimental background discussed above suggested that targeting 
syndecan-4 expression would be a useful approach to identifying the significance of this 
putative mediator of cell adhesion.  Furthermore, previous studies by García and others 
have demonstrated that cell detachment assays are sensitive methods to determine the 
cell-substrate adhesive interactions98.  Since a critical component of SMC migration 
involves alterations in their adhesion, we employed this type of assay in order to assess 
the involvement of syndecan-4 in SMC atherogenic potential. 
 
2.1.3 Methods of Analysis 
The purpose of using an antisense construct-containing adenoviral vector was to 
eliminate syndecan-4 expression at the messenger ribonucleic acid (mRNA) level.  We 
postulated that the presence of single-stranded mRNA in the antisense configuration 
would bind to native syndecan-4 mRNA, sequestering it, and rendering it (1) unavailable 
for translation, and (2) prone to rapid degradation.  The choice of an adenovirus as a 
means of transferring this antisense gene offered several advantages over other 
conventional vectors, such as retroviruses and electroporation.  Unlike many retroviral 
systems, adenoviral vectors have the potential for clinical application.  Moreover, the 
likelihood of phenotypic variants and the development of substantial compensatory 
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mechanisms often seen in knockout models are diminished.  A limitation of adenoviral 
systems, however, is that the transfection is transient. 
 
2.2 Materials and Methods 
2.2.1 Cell culture 
PAC-1 immortalized rat pulmonary artery SMCs were provided by Dr. Abraham 
Rothman (UCSD Medical Center, San Diego, CA).  Though immortalized, these cells 
retain expression of important markers of SMC phenotype, including angiotensin II, 
norepinephrine, and α-thrombin receptors, and also SMC isoforms of α-actin, myosin 
heavy and regulatory light chains, α-tropomyosin, meta-vinculin, phosphoglucomutase, 
and calponin115.  The cells were cultured using standard cell culture techniques.  Growth 
medium consisted of M199 Medium (Invitrogen), supplemented with 10% FBS, L-
glutamine (Mediatech), 100 U/L penicillin, 100 µg/L streptomycin, and 10 U/L 
amphotericin B (Mediatech).  Quiescence medium consisted of growth medium, 
supplemented with 0.5% FBS.  Cells were incubated at 37ºC, 5% CO2, in a humidified 
atmosphere. 
 
2.2.2 Recombinant Adenovirus Construction and Infection 
Adenoviral vectors containing antisense syndecan-4 DNA in order to block the 
synthesis of syndecan-4 RNA were employed.  Ribonuclease protection assay (RPA) was 
used to investigate the infection efficiency.  The pAdTrack-CMV and pAdEasy-1 
vectors116, as well as E. coli BJ5183 cells were provided by Dr. Bert Vogelstein (Johns 
Hopkins University, Baltimore, MD).  Generation of a recombinant syndecan-4 antisense 
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virus, containing a green fluorescent protein (GFP) reporter, and amplification in 293 
cells were performed as described previously116.  Briefly, a 691 bp Hind III/Not I 
fragment comprising full-length rat syndecan-4 cDNA was cut from a pcDNA3.1(+) 
plasmid and ligated into the pAdTrack-CMV shuttle vector to form pAdTrack-
CMV/antisense.  PAdTrack-CMV/antisense was linearized with Pme I and co-
transformed with pAdEasy-1 into BJ5183 bacterial cells to achieve homologous 
recombination.  Recombinant adenoviral constructs were isolated and transfected into 
293 cells (Qbiogene, Carlsbad, CA) using a standard lipofectamine (Invitrogen) 
transfection.  Seven to ten days post-transfection, virus was harvested by scraping and 
pelleting the transfected 293 cells, resuspending in sterile PBS, and freeze-thawing for 3 
cycles.  The cell debris was pelleted and the supernatant used to re-infect 293 cells for 
amplification.  Virus was amplified for 4 cycles using the harvesting and re-infection 
process described above.  Titration of the virus was performed by infecting 293 cells for 
18 hours with serially-diluted viral stocks and counting positive cells through GFP 
fluorescence.  Virus stock titers of 1.4 to 5.7x108 plaque forming units (pfu)/mL were 
retained and used for experiments. 
For infection, cells were briefly incubated at 37ºC with a multiplicity of infection 
(MOI) of 10, representing the number of virus particles per cell, in Quiescence medium.  
After 1.5 hours, growth medium was added, and the cells were cultured for up to 24 
hours.  Cells were then detached with 0.5% Trypsin (Mediatech) and passaged into 10 cm 
and 96-well culture dishes.  After the cells reached confluence they were either harvested 




2.2.3 RNA Analysis 
To quantify syndecan-4 gene expression in PAC-1 cells, a ribonuclease protection 
assay (RPA) kit was used according to the manufacturer’s instructions (Promega, 
Madison, WI; Ambion, Austin, TX).  Briefly, total RNA was extracted by adding 3 mL 
TRIzol (Gibco BRL) to cells growing in a 100 mm culture dish.  After 5 minutes, the 
cells were scraped from the dishes into microcentrifuge tubes.  Following chloroform and 
isopropanol extractions, and rinsing with 75% ethanol, the RNA was re-suspended in 
RNase-free water.  The RNA concentration was determined by measuring OD260.  
Riboprobes (Table 1) were generated to the extracellular domains of rat syndecan-4 by 
sub-cloning the PCR product into the pCR vector system (Invitrogen).  The vector was 
linearized, and corresponding sense and antisense probes were transcribed, using a T7 
promoter in the presence of 32P labeled UTP (Amersham).  The target syndecan-4 mRNA 
was quantified by hybridizing 10 µg of the extracted mRNA with the radiolabeled probes 
and running the samples on a 5% polyacrylamide/8M urea gel.  A commercially available 
Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) RNA template (BD Biosciences 
– Pharmingen, San Jose, CA) was also radiolabebeled and used as an internal control.  10 
µg of extracted RNA was used for each sample.  BioMax MS autoradiography film was 
exposed to the resolved gels at -80ºC and used to visualize the position of the bands.  




Table 1. Oligonucleotide primer sequences for rat syndecan-4 riboprobes. 
 
Primer Sequence PCR Size 
Forward 5’- AGG CGA GTC GAT TCG AGA GA -3’ 398 bp 
Reverse 5’- TCA GAG CTG CCA AG ACCT CT -3’ 398 bp 
 
 
2.2.4 Surface Adsorption 
The relationship between bulk solution and surface concentrations of heparin-
binding peptides was quantified by radiolabeling the peptides with 125I (NEN Life 
Science, Boston, MA) and adsorbing different concentrations to the surfaces of glass 
beads.  The tyrosine-containing peptides were radiolabeled using IODO-Beads Iodination 
Reagent (Pierce Biotechnology, Rockford, IL) according to the manufacturer’s 
instructions.  Briefly, 1 mCi Na125I per 100 µg target protein was oxidized and 
incorporated into the protein, using PBS pH 7.2 as the reaction buffer.  The reaction was 
terminated by removing the beads from the mixture.  Unincorporated 125I was removed 
using a D-Salt Desalting Column (Pierce).  The protein was precipitated by incubation in 
10% trichloroacetic acid (TCA) for 45 minutes, followed by centrifugation at 16,000 x g 
and washing of the pellet twice with 10% TCA.  The amount of radioactivity in the pellet 
was measured using a γ-counter (LKB-Wallac RiaGamma 1274, Wallac Oy, Finland).  
The protein concentration was determined using the Bradford method (Bio-Rad), and the 
specific activity (SA) in cpm/µg was then calculated and used for surface density (SD) 
determinations. 
Cover slips (15 mm diameter) were used to determine adsorption onto glass.  The 
discs were incubated with the 125I-labeled protein, diluted 1:100 in unlabeled protein, and 
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incubated at 4ºC for 24 hours.  The discs were then blocked with 1% BSA in PBS at 
room temperature for 45 minutes, and then washed with PBS.  The adsorbed radioactivity 
of each disc was determined using a γ-counter.  The protein concentration vs. SD was 











2.2.5 Glass Microsphere Adhesion Assay 
Cell-substrate adhesive strength was determined by employing a modified 
centrifugation assay (Figure 3).   Details of this assay are described in Appendix A and 
elsewhere117.  Briefly, human plasma FN was pre-adsorbed onto 30-50 µm glass 
microspheres (Polysciences, Warrington, PA) by incubating them in 100 µg/mL of the 
protein at 4ºC for at least 24 hours.  The microspheres were then washed five times with 
PBS, blocked with 1% BSA in PBS for 45 minutes at room temperature, and washed 
three more times in PBS.  At this point, the microspheres were suspended in serum-free 
medium (MCDB 104 Medium, Gibco BRL) supplemented with Supplement-X (10 mg/L 
insulin, 5.5 mg/L transferrin, 6.7 µg/mL sodium-selenite; Gibco BRL), 2 mM L-
glutamine (Mediatech), 1 mM CaCl2 and Penicillin/Streptomycin.  PAC-1 cells were sub-
cultured at an initial density of 3x105 cells/mL into each of the 72 inner wells of a 96-
well culture-treated strip plate (Corning, Corning, NY) and cultured in growth medium 
until 80% confluent (approximately 4 days).  The cells were then quiesced for 24 hours, 
rinsed twice with PBS, and 200 µL of the microsphere suspension was placed in each 
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well on top of the cell monolayer.  Selected cells were treated with sodium chlorate at 
this point.  Chlorate, a competitive inhibitor of ATP-sulfurylase, results a loss of GAG 
sulfation.  The result is that sulfated GAG-mediated interactions are eliminated.  Up to 75 
mM sodium chlorate has been used with smooth muscle cells without evidence of 
cytotoxicity118-120.  The cells were incubated for 6 to 8 hours at 37ºC, after which the strip 
wells were detached in sets of two, placed inverted into a 12-well plate, filled with 0.01% 
BSA in PBS (Figure 3).  Each plate was placed in a swing-bucket holder and centrifuged 
(Thermo EC, Waltham, MA), at designated speeds ranging from 500-3400 rpm 
(approximately 50-2500 x g) for one minute from the time maximum angular velocity 
was reached.   
In this assay a range of detachment forces was applied to a population of matrix-
coated glass microspheres, and the quantity of beads that adhered to the monolayer of 
cells upon inversion of the culture dish varied in a time-dependent manner.  In plotting 
the percentage of adherent microspheres vs. the relative centrifugal force (RCF), the force 
value at which 50% of the microspheres detached could be determined and was 
designated as RCF50.   For example, the RCF50 was approximately 500 ± 100 x g for FN-
coated glass microspheres that had been deposited and incubated for 6 hours on a 
monolayer of PAC-1 cells. 
Different samples were centrifuged for 1 minute in increments of 500 rpm.  Each 
well was then viewed at 40X magnification using an inverted microscope (Nikon, 
Melville, NY) with ambient visible light illumination.  The reflection of the rounded 
microspheres provided adequate contrast with low background noise, and enabled precise 
image measurements.  Since the area covered by the microspheres was proportional to the 
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total number attached to the cells, the fraction of glass microspheres remaining was 
determined by measuring the covered area, using IP Lab Spectrum image analysis 
software (Scanalytics, Fairfax, VA).  The results were fit to the following symmetrical 
logistic model (Equation 2.2), using the Marquardt-Levenberg algorithm, where f is the 
percent adherent glass microspheres, f0 is the percent adherent at zero force, b is the 
decay slope, and RCF was measured in gravitational units, g.  The parameters b and 
RCF50 were then calculated: 
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2.2.6 Statistics and Data Analysis 
Values are reported as mean ± standard error of the mean (SEM).  Statistical 
analysis was performed using SigmaStat 3.0 software package (SPSS, Chicago, IL).  
Student’s t-test was employed for individual comparisons, while analysis of variance 
(ANOVA) was employed, using the Tukey’s method, for multiple pairwise comparisons 












Figure 3. Scheme for cell adhesion experiments.  PAC-1 cells were grown in 96-well 
strip plates.  At confluence, glass microspheres, pre-adsorbed with FN, were placed onto 
the cell monolayer and incubated for 8 hours.  The wells were then inverted and 
centrifuged in order to separate the microspheres from the cells, after which the area 





2.3.1 Centrifugation Assay is a Convenient Tool for Evaluating Cell-ECM Adhesion 
The glass microsphere adhesion assay was used to quantify cell-substrate 
adhesiveness.  This assay required that several assumptions be made:  (1) the cells 
formed an intact monolayer on the polystyrene culture plate which could not be disrupted 
by the conditions imposed by the assay; and  (2) the substrate under investigation was the 
surface of the glass microspheres, rather than the polystyrene culture plate, and as such, 
the strength of the cell-substrate interaction needed to be within the measurement limits 
of the assay.  To test this, the cells were initially imaged after centrifugation at the 
maximum force of 2500 x g.  We also imaged the cells after all microspheres themselves 
had initially adhered for 8 hours prior to centrifugation at 2500 x g (Figure 4).  The fact 
that the cell monolayer remained intact following both conditions suggested that the 
adhesive interaction between the cells and the glass microspheres was within the working 
range of, and could therefore be evaluated by, this assay.  Furthermore, the result 
suggested that the strength of adhesion between the cells and the culture plate was above 
this range. 
 
2.3.2 Adhesive Strength is Influenced by Post-Translational Sulfation and Syndecan-4 
Regulation 
Prior evidence has demonstrated that N- and O-sulfation of the HS chains are 
necessary for many of the biological functions of HSPGs, including syndecans, and these 
substitutions greatly influence the binding affinity of HSPGs to soluble matrix 
proteins73,121,122.  Our current experiments demonstrated this to be true for the role of 
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syndecan-4 in mediating cell-substrate adhesive interactions.  Elimination of HS sulfation 
with sodium chlorate treatment reduced adhesive forces between the FN-coated glass 
microspheres and the SMC monolayer, as indicated by a reduction in RCF50 by 76% of 
untreated controls (Figure 5). 
While the results with sodium chlorate implicated a critical role of sulfated 
biomolecules in SMC adhesion, they did not address the specific role of HSPGs or 
syndecan-4 in particular.  To answer the question of whether syndecan-4 regulation 
influenced cell adhesion, we employed an adenovirus transfection strategy to interfere 
with syndecan-4 expression.  The results demonstrated that the cells were cultured 
successfully after infection with an adenovirus MOI of 10.  As shown in Figure 6A, the 
infection did not significantly alter the morphology of the cells, and they were able to 
form a confluent monolayer.  Using GFP as a housekeeping indicator of infection with 
our adenoviral construct, Figure 6B and Figure 6C also demonstrate that the infection 
was sustained after a week in culture, which was the maximum duration that the cells 
were cultured prior to running the adhesion experiment.  Once we demonstrated that 
transfection was stable and non-cytotoxic by our measurements, we quantified the level 
of syndecan-4 RNA produced by the transfected cells, and compared them with non-
transfected controls (Figure 7).  Using radiolabeled riboprobes to detect syndecan-4 and 
GAPDH RNA (inset), we found that the syndecan-4 RNA from these cells, after internal 
normalization to GAPDH RNA, was reduced by 78% of non-transfected controls. 
To test the functional significance of this decrease in detectable syndecan-4 RNA, 
we compared (1) cells treated with the antisense genetic construct-containing adenovirus 
with (2) those treated with a null (empty vector) construct-containing adenovirus and (3) 
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normal, non-transfected controls (Figure 8).  The results indicated that, regardless of the 
genetic contents of the adenoviral vector, a significant difference in cell adhesive 
behavior existed between transfected and non-transfected SMCs.  The antisense 
construct-transfected cells displayed an adhesive strength that was reduced by 56 ± 2% of 
the non-transfected controls (p value < 0.001), while the null construct-infected cells also 
displayed reduced adhesive strength (26 ± 2% of the non-transfected controls; p value < 
0.001).  More importantly however, a significant difference existed between the antisense 
and null vectors (p value < 0.001).  In other words, the decrease in SMC adhesive 
strength that was associated with the reduction of syndecan-4 RNA was two-fold greater 
than with the presence of the empty vector control alone.  Taken together, these results 
indicate that there was a marginal nonspecific effect due to transfection with the null 
vector; however, a much greater reduction in adhesive strength was observed in cells in 












Figure 4. Demonstration that cell monolayer remained adherent to culture dish 
following adhesion assay.  Cells were cultured in 96-well plates, and FN pre-adsorbed 
glass microspheres were incubated on the cells for 8 hours.  The plates were then 


































Figure 5. Decrease in adhesive strength due to treatment with sodium chlorate.  At 
the time the glass microspheres were placed on the cells, sulfation of new GAG chains 
was inhibited by treatment with 30 mM sodium chlorate.  Cell-substrate adhesive 
strength was determined by employing a glass microsphere centrifugation assay, in which 
a range of detachment forces were applied to a population of matrix-coated microspheres 
deposited onto a SMC monolayer.  Adhesive strength was reduced by 76% compared to 





















Figure 6. Evidence of adenovirus infection.  Cells were viewed under at 100X 
magnification, using an inverted microscope with either a phase contrast (A) or an 
epifluorescence attachment (B and C).  Adenovirus constructs carried a GFP reporter 
gene which allowed for the identification of transfected PAC-1 cells.  After 20 hours (B) 
and seven days (C) in culture, infected cells were identified by GFP expression.  The 



































Figure 7. Reduction in syndecan-4 RNA after adenovirus infection.  Cells were 
infected for 72 hours with a MOI of 10.  Riboprobes were generated to the extracellular 
domains of rat syndecan-4 and corresponding sense and antisense probes were 
transcribed.  The RNA was extracted, analyzed by RPA, and quantified by densitometry, 
using image analysis software.  Measured RNA levels of the infected cells were reduced 
by 73%, compared to the uninfected controls.  Inset: RPA results, indicating uninfected 
control (U) and antisense (A) RNA, detected with syndecan-4 and GAPDH (endogenous 












































Figure 8. Decrease in adhesive strength as a result of a reduction in syndecan-4 
RNA.  Cells were either uninfected or infected with 10-30 MOI of adenovirus contructs 
containing a null (empty vector) or an antisense genetic construct.  After one additional 
passage post-transfection, the cells were used in the centrifugation adhesion assay.  Data 
were normalized to uninfected controls, and the results were obtained from at least three 
replicates.  Differences between all groups are significant.  ANOVA was performed, 





















2.4.1 Syndecan-4 Regulation as a Means to Modify Cell Adhesion 
Regulation of cell adhesion is a fundamental requirement for the normal function 
of cells in the blood vessel wall.  SMCs, in particular, balance their adhesiveness and 
migratory characteristics based upon cues – chemical and mechanical – from their 
surrounding environment.  These cues direct the cells to regulate the assembly, activity, 
and secretion of adhesion-related molecules, and to reorganize existing ECM 
components.  Cell locomotion depends on a balance between cell adhesiveness and 
motility, which is directly affected by ECM composition and receptor density104,123.  In 
particular, syndecan-4 has an established role in promoting the assembly of focal 
contacts, and subsequent cell adhesiveness.  Through alterations in cell adhesion and 
locomotion, syndecan-4 regulation ultimately results in blood vessel remodeling, 
including restenosis and atherosclerotic plaque development. 
The goal of our adhesion experiments was to examine the effectiveness of 
syndecan-4 regulation in the multi-step process of cell spreading and establishment of 
vascular SMC adhesive interactions.  The highly sulfated pendant chains of syndecan-4 
were the targets for our initial experiments using sodium chlorate.  This chemical 
reversibly inhibits GAG sulfation, and therefore served as a first approximation of the 
importance of sulfated GAGs in general on the adhesion strength of spread cells.  One 
recognized limitation of the sodium chlorate strategy was that sulfation inhibition was not 
restricted to GAGs, raising the possibility that unintended inhibition of sulfate-dependent 
cellular events may have confounded any observed alteration in adhesive strength.  
Despite this potential source of error, we noticed that the adhesion strength was indeed 
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reduced, and we were thus motivated to examine the effect that the highly sulfated 
syndecan-4 molecule in particular had on this process. 
The studies outlined above also demonstrate the usefulness of our adenoviral 
system to selectively regulate syndecan-4 gene expression in order to examine its effects 
on cell adhesion.  The use of an adenoviral vector as a means of specifically targeting 
syndecan-4 expression provided several advantages.  In this system, sustained 
transfection for at least a week after the initial infection was verified by both the presence 
of GFP expression, indicating the presence of a co-transfected reporter gene, as well as 
RPA data showing reduced syndecan-4 mRNA.  Additionally, the normal cytological 
appearance of the cells a week after transfection indicated that the cells remained viable.  
Unfortunately, verification of reduced syndecan-4 protein expression in the transfected 
cells was not possible due to the lack of a suitable anti-rat syndecan-4 antibody at the 
time of experimentation.  However, in these adenovirus-infected cells, the marked 
reduction in adhesive strength in the presence of antisense construct beyond the effect of 
the null vector alone supported a role for syndecan-4 expression in adhesion generation.  
Despite the limitations of potent immunogenicity, an adenovirus system offers relative 
advantages over other transfection strategies, including the ability to shuttle large 
transgenes, replicate in high titer, and stably transfect target cells.  Other 
transfection/transduction strategies, including electroporation, liposome-mediated, and 
retroviral methods suffer from variability, low efficiency, cell mortality, or safety 
concerns.  An additional strategy is the use of genetic knockout models, where impaired 
wound healing has been demonstrated in both syndecan-1 and syndecan-4 knockout 
mice, each apparently due to separate processes124-126.  However, despite recent success 
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using these models, genetic knockout methodologies often result in animals with an 
unpredictable phenotype, or who may not be viable or fertile. 
 
2.4.2 Adhesion Assay Limitations 
The assay employed in our experiments, though useful in its ability to measure 
cell-substrate adhesion, contained some inherent limitations.  One limitation was that our 
measurements did not account for the fact that the RCF experienced by the cell 
monolayer varied during the experimental procedure, based on the time it took for the 
centrifuge to accelerate to (and decelerate from) the desired angular velocity.  Although 
the target speed in each experiment was maintained for one minute, the duration of the 
acceleration and deceleration periods depended on the final speed.  For example, the 
centrifuge required approximately 10 seconds before measuring 500 x g, while it required 
approximately 25 seconds before measuring 1500 x g. 
In addition to this nonlinear acceleration, the detachment profiles of our FN pre-
adsorbed glass microspheres at a constant RCF were likely nonlinear functions of time 
(Figure 9).  Since a critical requirement of the assay was that, at a given RCF, each 
sample needed to be centrifuged for a length of time after which no additional 
microspheres detached from the cell monolayer, a one minute time period was chosen in 
order to allow for the microspheres to detach at all forces available in the assay.  It was 
assumed that any additional amount of time would not yield a significant decrease in 


























Figure 9. Predicted detachment profiles of FN pre-adsorbed glass microspheres 
adherent to a SMC monolayer.  In our experiments, we assumed that for each applied 
RCF the percent adherent microspheres decreased as an undetermined, nonlinear function 
of time, but that by 1 minute (dotted line), no significantly additional detachment 




Another limitation of the selected assay was that it enabled the quantification of 
global, population-based, rather than single cell or receptor adhesion parameters.  Unlike 
micromanipulation techniques, which are able to isolate the adhesive forces between a 
limited number of individual receptors, our assay applied a relatively uniform detachment 
force to all cells in a given experiment.  Thus, potentially important cell-to-cell and even 
single receptor differences may have been underappreciated.  In addition, a potential 
source of error could arise due to an effect of syndecan-4 regulation on other adhesion 




not directly related to syndecan-4.  An example of this has been demonstrated by the 
effects of syndecan-1 regulation in mammary epithelial cells127.  In this system, down-
regulation of E-cadherin occurred in concert with syndecan-1, resulting in altered cell-
cell interactions. 
Overall, our experimental system served as a simple and sensitive technique to 
assess well-established cell-ECM adhesive interactions on a defined substrate.  As a 
functional assay, our strategy offered distinct advantages over other methods, including 
other types of centrifugation96,128-130, micromanipulation94,95,131-133, and hydrodynamic 
flow97,98,134-140.  In other centrifugation assays, the maximum force generated is 
insufficient to detach well-spread cells.  In micromanipulation assays, time, cost, and 
investigator variability limit the assay’s usefulness and reliability.  In hydrodynamic flow 
assays, the need for specialized equipment and the dependence of the applied force on 
cell morphology restrict the assay’s widespread use and adaptability141.  Despite the 
limitations of each, the various adhesion assays have been used to demonstrate the 
importance of cell adhesion in vascular biology87,142,143.  For example, it has been shown 
that during periods of angiogenesis, physiologic remodeling, and responses to vessel 
injury, this process is particularly dramatic.  SMCs and myofibroblasts alter their 
adhesive characteristics, proliferate, and migrate within the vessel wall114,144,145, often 





REGULATION OF SYNDECAN GENE EXPRESSION IS INFLUENCED  
BY MECHANICAL STRAIN 
 
The local mechanical environment in the vascular wall regulates many functions 
of the resident cells.  This fact is particularly evident in the medium and large arteries, 
where the magnitude of the hemodynamic fluctuations varies under different physiologic 
and metabolic conditions.  Using vascular SMCs as a model system, our aim of was to 
use a well-characterized technique to mechanically strain the cells under controlled and 
reproducible conditions for the purpose of evaluating the transcriptional regulation of 
syndecan-4.  As a means of comparison, we also investigated the regulation of other 
HSPGs expressed by SMCs, namely syndecan-1 and syndecan-2.  We postulated that 
syndecans, increasingly well known for their involvement in cell-matrix interactions and 
growth factor signaling, were candidates for cyclic strain-induced modulation. 
 
3.1 Background and Significance 
3.1.1 Vascular Wall Mechanics and Physiologic Effects 
Regulation of vascular hemodynamics takes place at several levels: self-
regulation, central and autonomic control, and hormonal control.  This regulation serves 
either to alter the flow of blood traveling within the vessel or to alter the mechanical 
properties of the wall itself.  Several workers have modeled the mechanics of the arterial 
wall in terms of the stresses present during physiologic and pathologic loading18,146,147.  
These stresses include hydrostatic pressure, fluid shear, and circumferential tension; and 
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the nature and duration of these same stresses are potentially critical factors in the type 
and the extent of an injury outcome.  In particular, periodic deformations, resulting from 
the cardiac cycle, are imparted on the constituents of the vessel wall and play a 
significant role in creating an optimal biomechanical microenvironment essential for 
normal cell function.  Thus, it has become increasingly apparent that alterations in the 
local mechanical environment, both acute versus chronic, and static versus cyclic, may be 
important factors that initiate and modulate cellular responses to injury.  In fact, cyclic 
strain has been shown to stimulate collagen synthesis by SMCs148, activate extracellular 
signal-regulated mitogen-activated protein kinase (ERK) 1/2 149, as well as induce 
intracellular trafficking and protein phosphorylation150,151.  The stresses that accompany 
direct tissue injury activate SMCs and modulate gene expression and cell 
differentiation152.  Thus, changes in the local mechanical environment of the vascular 
wall can induce the activation and transformation of SMCs from a quiescent to a 
synthetic phenotype, and we therefore found it necessary to analyze cellular responses to 
defined mechanical conditions. 
Among the stresses transmitted to SMCs in the vascular wall during injury 
(Equation 1.1), for the purposes of this study, our model system focused our analysis on 
circumferential tension, and we evaluated the resulting regulation of syndecan-4 gene 
expression.  Admittedly, an examination of the interplay of all of these mechanical 
elements will eventually provide the most significant insight into in syndecan-4 
regulation; however, we chose three mechanical microenvironments which appear to be 
particularly relevant to the development of lesions within the vascular wall.  First, an 
acute increase in static tension is produced during cardiopulmonary bypass for coronary 
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artery and cardiac valve repair153, and during percutaneous transluminal coronary 
angioplasty (PTCA) and stenting procedures (increased P and R).  Although not modeled 
in our studies, PTCA actually produces forces that are great enough in magnitude to 
stretch and even split components of the vessel wall25-27,154.   Second, an acute increase in 
cyclic tension results during physical or metabolic conditions that transiently increase 
blood pressure (increased P).  Finally, a persistent or chronic increase in cyclic tension 
may be manifest in clinical conditions such as untreated or poorly controlled 
hypertension or an aortic aneurysm (increased R), while a chronic decrease in cyclic 
tension may be associated with atherosclerosis, intimal hyperplasia, and restenosis 
(decreased R; increased h and E).  In summary, the purpose of our in vitro model assay 
was to replicate specific examples of in vivo mechanical forces experienced by vascular 
SMCs and gain insight into syndecan regulation. 
 
3.1.2 Cyclic strain device 
Periodic hoop stress is the predominant force on cells in the media and adventitia 
of blood vessels18.  Due to the transmural pressure across the vessel wall, this stress in 
turn results in radial and circumferential strains.  The experiments outlined below were 
performed using SMCs grown on a FN-coated silicone elastomer, which could be 
subjected to mechanical tension.  Previous strain devices principally employed uniaxial 
stretch of rectangular membranes or biaxial stretch of membranes of various geometries.  
These geometries were typically circular, and deformation of the membrane was induced 
by means of a platen-driven assembly or a pressure gradient.  In order to circumvent the 
inherent problems of strain heterogeneity and anisotropy of the popular Flexercell Strain 
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Unit (Flexcell International Corp)155-161, in-plane membrane stretch devices were 
developed.  Schaffer et al. and Hung and Williams162 were the first to describe the use of 
a type of device capable of applying equibiaxial (radial = circumferential) strain to a 
monolayer of cells163.  We have previously used this device in our lab to recapitulate 
balloon angioplasty injury164.  The mechanism of this device is in contrast to the 
commonly used vacuum pressure-driven ones.  Until recently, these various pressure-
driven devices were limited by non-uniform strain fields, resulting in a gradient of 
membrane stress with distance from the center of the plate.  Notably, Chen et al. used a 
vacuum-driven device to impart 10% average strain at 1 Hz to cells growing on an elastic 
membrane.  This level of strain has been shown to be relevant physiologically to that 
present in large arteries (aorta, carotid, femoral, brachial) 165,166.  For our purposes, we 
used a truly equibiaxial strain device as an in vitro correlate for the in vivo 
micromechanical environment of the native vessel164. 
 
3.1.3 Heparan Sulfate Proteoglycan / Syndecan Biology 
The principal way cells sense changes in and communicate with their 
environment is through their cell surface receptors, and it has become well known that 
cells respond to local hemodynamic changes by remodeling their surrounding ECM in 
order to counteract or minimize these changes16,167.  Since remodeling requires changes 
in adhesive characteristics and/or elaboration of effector molecules into the surrounding 
milieu, we therefore looked to the syndecans as candidate mediators this response. 
Though syndecan-4 was the focus of the adhesion experiments, regulation of 
syndecan-1 and syndecan-2 have also proven to be of interest for several reasons.  One 
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reason is the functional similarity between syndecan-1 and syndecan-4, as indicated by 
their similar ability to promote intercellular adhesion in a study of B lymphoid cells168.  
Since the ectodomain primary sequences of these two syndecans are quite dissimilar, it 
has been suggested that they may resemble each other in conformation, either as 
monomers or as aggregates65.  The conclusion was that a secondary or tertiary structural 
resemblance could be responsible for similar action.  A second reason for our interest in 
other members of the syndecan family is the involvement of syndecan-2 in several cell-
ECM interactions, such as FGF-induced fibroblast adhesion169, and the regulation of actin 
stress fiber organization in lung carcinoma cells170.  Lastly, the ability of the HS chains to 
interact non-specifically with a host of soluble and insoluble ligands, when attached to 
both cell surface and shed syndecan ectodomains, suggests a role for them in remodeling 
events. 
Our aim was therefore to characterize the gene expression of syndecan-4 under 
series of well defined strain protocols, particularly as it relates to the expression of 
syndecan-1 and syndecan-2.  Strain protocols were chosen such that they mimicked 
specific in vivo situations known to occur under different physiologic and pathologic 
circumstances, enabling us to gain insight into the consequences of certain disease states 
or clinical interventions on vascular wall cell biology.  
 
3.2 Materials and Methods 
3.2.1 Cell Culture 
Clonetics normal human aortic smooth muscle cells (SMC), culture medium, and 
supplements were obtained from Cambrex Bio Science (Walkersville, MD), and the cells 
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were sub-cultured using standard techniques.  Smooth Muscle Cell Growth Medium-2 
(SmGM-2) was prepared according to the supplier’s recommendations (Smooth Muscle 
Basal Medium (SmBM), supplemented with 5% fetal bovine serum (FBS), 500 µg/mL 
human epidermal growth factor (hEGF), 5 µg/mL insulin, 2 mg/mL human fibroblast 
growth factor (hFGF), 50 µg/mL gentamycin, and 50 mg/mL amphotericin-B.  Cells were 
maintained in tissue culture-treated petri dishes at 37ºC, 5% CO2, and humidified 
atmosphere.  Growth medium was changed every two days, and the cells were passaged 
1:4 when the dishes were 80% confluent, using 0.05% Trypsin / 0.53 mM EDTA 
(Invitrogen Life Technologies, Carlsbad, CA).  Experiments were performed on cells 
between passages 6 and 10 using Quiescence medium, which consisted of basal medium 
supplemented with 0.5% FBS, 50 µg/mL gentamycin, and 50 mg/mL amphotericin-B. 
 
3.2.2 Mechanical Strain Application 
Strain dishes were assembled in the following manner: the bases of bottomless, 
custom-made plastic petri dishes were fitted with a silicone membrane (0.005” thickness; 
40 Durometer; Specialty Manufacturing, Saginaw, MI).  The silicone served as the 
flexible growth area of the strain dishes.  5 µg/mL of human plasma fibronectin (FN; 
Sigma) in PBS was pre-adsorbed to the growth area for at least 8 hours at 4ºC, serving as 
a substrate for cell attachment.  The cells were then seeded onto the membranes, cultured 
to 80% confluence in SmGM-2, and then growth-arrested for 24 hours in Quiescence 
medium.  Depending on the experimental conditions, defined static or cyclic tension was 
applied to the cells using a StrainMaster apparatus (Z-Development, Inc., Cambridge, 
MA; Figure 10)171.  All strain protocols were performed at 1 Hz, in order to mimic the 
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“normal” adult heart rate of 60-80 beats per minute.  As shown in Figure 11, the cells 
were subjected to different regimens of cyclic or static strain.  For a given protocol, the 
cells were either cyclically strained at 1 Hz or held static, and the RNA was harvested at 
various time points up to 24 hours.  Alternatively, the cells were strained at different 
magnitudes, under either cyclic or static conditions, after which the cells were harvested 
simultaneously.  Lastly the cells were preconditioned by subjecting them to a physiologic 
level of 10% cyclic strain172 for 24 hours, followed by 20% strain thereafter.  RNA was 
harvested at specific time points after the initiation of 20% strain. 
 
3.2.3 Cell Viability 
In order to ensure that the different treatments were not cytotoxic, Live/Dead 
Viability/Cytotoxicity assays were performed in order to assess cell viability/injury.  
Cells were grown to 80% confluence in SmGM-2 and Quiesced for 24 hours.  They were 
then subjected to one of the experimental conditions.  They were then rinsed once with 
PBS and a solution containing 0.5 µM calcein AM and 1 µM ethidium homodimer in 
PBS (Molecular Probes, Eugene, OR) was added for 15 minutes at 37ºC.  The cells were 
then observed for the generation of red or green fluorescence, using an inverted 
microscope with epifluourescent illumination (Olympus, Melville, NY) at 100X 
magnification. 
 
3.2.4 Human Aortic SMC RNA Analysis 
To determine syndecan gene expression in human aortic SMCs, real time 
quantitative PCR was used.  Briefly, total RNA was harvested either by using the TRIzol 
 
 50
reagent (Gibco BRL) or the RNeasy Mini kit with DNase digestion (Qiagen, Valencia, 
CA).  The cells growing in a 100 mm culture dish were removed using a cell scraper, and 
then transferred to microcentrifuge tubes.  The TRIzol-treated cells were extracted with 
chloroform and isopropanol, followed by rinsing with 75% ethanol.  RNA was re-
suspended in RNase-free water, and the concentration was determined by measuring 
OD260.  The absence of significant DNA or protein contamination was verified by 
determining the OD260/OD280 ratio.  cDNA was generated from the extracted RNA using 
SuperScript III reverse transcriptase (Invitrogen).  5 µg RNA was used in each reaction.  
For real time PCR analysis, TaqMan Gene Expression Assays (Applied Biosystems, 
Foster City, CA) were used.  Assay sets contained proprietary forward and reverse DNA 
primers and 5,(6) carboxyfluorescein (6-FAM)-labeled probes specific to the gene of 
interest were selected from Applied Biosystems’ database of genomic assays (Table 2).  
Assay ID’s Hs00174579_m1 (syndecan-1), Hs00299807_m1 (syndecan-2), and 
Hs00161617_m1 (syndecan-4) were selected.  Additionally, Hs99999901_s1 (18S rRNA) 
and Hs99999903_m1 (β-actin) were selected for use as endogenous controls.  
Amplification and detection were performed on an ABI Prism 7000 Sequence Detection 
System (Applied Biosystems), using AmpliTaq Gold DNA Polymerase (Applied 
Biosystems) in a 5’ nuclease reaction. 
Data generated from the target gene amplification was normalized to the 
simultaneously amplified endogenous controls in order to quantify expression levels that 
were robust to incidental experimental variation.  Gene expression in the treated groups 




Table 2. Real time PCR DNA primer and probe sets obtained from the TaqMan Gene 
Expression Assays database of Applied Biosystems 
 
Target Gene Assay ID 
Human Syndecan-1 Hs00174579_m1 
Human Syndecan-2 Hs00299807_m1 
Human Syndecan-4 Hs00161617_m1 
Eukaryotic 18S rRNA Hs99999901_s1 
Human β-actin Hs99999903_m1 
 
 
3.2.5 Statistics and Data Analysis 
Values are reported as mean ± SEM.  Statistical analysis was performed using 
SigmaStat 3.0 software package.  ANOVA was employed, using the Holm-Sidak test for 
multiple pairwise comparisons among the treatments.  When applicable, logarithmic 
transformation of the data was necessary prior to statistical analysis in order to make the 
error variance independent of the mean.  In other cases, the Kruskal-Wallis ANOVA on 
Ranks non-parametric test was used.  A p value < 0.05 was considered statistically 


































Figure 10. Schematic diagram (A) and strain profiles (B and C) of the StrainMaster 
apparatus to apply biaxial strain to a monolayer of cells in culture.  The dish 
containing adherent cells is secured onto a docking collar.  The circular silicone 
membrane in each dish is deformed by a cup and platen assembly, as a motor-driven cam 
displaces the assembly in a sinusoidal manner.  Placement of the pivot determines the 
amplitude of the motion.  The theoretically determined radial and circumferential strain 
profiles demonstrate the ability of this device to apply isotropic and homogeneous strain 











Figure 11. Protocols for the application of mechanical strain.  SMCs were subjected 
to 1 Hz cyclic tension for various time periods and strain magnitudes (A).  Alternatively, 
the cells will be subjected to static tension, and the protocols were repeated (B).  Finally, 
the effect of preconditioning was examined by cyclically stretching the cells at 10% 
strain for 24 hours, followed by repeating the time-course cyclic tension protocol at 20% 
strain (C).  Arrows indicate sampling points, in which cells were harvested for syndecan 






3.3.1 Vascular SMCs Tolerate Mechanical Strain Without Gross Cytotoxicity 
As described in the Methods, the cell growth area consisted of a FN pre-adsorbed 
silicone membrane.  Both the membrane and the adherent cells were subjected to various 
degrees of mechanical strain.  The application of cyclic strain was accomplished using 
the StrainMaster apparatus, which allowed control over the frequency and amplitude of 
the radial and circumferential strains of the membrane.  The details and validation of the 
mechanical strain device are described elsewhere162,163,171.  Briefly, unlike fluid 
displacement173,174 and vacuum-driven strain devices155,175-177, the current apparatus was 
designed with the ability to apply homogeneous (positional invariance of the strain 
tensor) and biaxially uniform (directional equivalence) strains over the growth area of the 
membrane.  In other words, the radial and circumferential strains were equivalent 
( r θε ε= ). 
Cell viability/injury was investigated after each of the periods of mechanical 
strain.  In all cases, viability was assessed using a Live/Dead assay, in which calcein AM 
and ethidium homodimer were added to the cells.  Live cells, containing active esterases, 
converted the calcein AM to calcein, which produced green fluorescence (~515 nm); 
conversely, injured/dead cells were permeable to the ethidium homodimer, which 
produced red fluorescence (~635 nm) when bound to DNA.  As Figure 12 demonstrates, 
most cells stained green, while only a few red-stained ones could be identified, indicating 
that cells remained viable under all conditions under study.  These conditions were 
representative of those imposed on the cells in the subsequent syndecan gene expression 












































































































































































































































































































































































3.3.2 Static Strain Induces Differential Gene Expression Between the Syndecans 
Isolated RNA was used for analysis of syndecan-4 gene expression under multiple 
experimental mechanical strain conditions.  For most studies in which the expression 
pattern of syndecan-4 was analyzed, we also compared the syndecan-4 regulation to that 
of syndecan-1 and syndecan-2.  We first investigated the effect of in vitro administration 
of two levels of static strain on the kinetics of syndecan gene expression over a 24 hour 
time period.  When subjected to 5% static strain, syndecan-4 exhibited a modest rise to 
141 ± 40% of unstrained control at 4 hours.  Over the remaining 20 hours of the 
experiment, however, syndecan-4 gene expression fell significantly, when compared to 
the 4 hour levels, to 79 ± 10% of unstrained control (Figure 13C).  When subjected to 
10% static strain, the trend was similar to the response to 5% static strain, but the change 
in magnitude was not significant.  At 4 hours, gene expression was only 110 ± 2% of 
unstrained control, whereas at 24 hours, it was 76 ± 4% (Figure 14C). 
When subjected to 5% static strain syndecan-1 exhibited no significant change at 
any of the time points observed, ranging from 74 ± 13% of unstrained control at 4 hours 
to 87 ± 20% at 24 hours (Figure 13A).  There were significant differences in the 
syndecan-2 expression, and the pattern was similar to syndecan-4.  Like syndecan-4, 
syndecan-2 expression initially rose slightly to 118 ± 14% of unstrained control (at 1 
hour), then levels then fell moderately to 70 ± 8% of unstrained control at 24 hours 
(Figure 13B), which was a significant reduction from the 1 hour levels. 
At the 10% static strain level, there was again no significant change in syndecan-1 
gene expression, ranging from 98 ± 45% to 109 ± 20% of unstrained control after 4 and 
24 hours, respectively (Figure 14A).  On the other hand, syndecan-2 again resembled the 
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syndecan-4 response; however, the magnitude of the syndecan-2 response was significant.  
Following the initial 4 hours of strain, in which no significant change occurred, 
syndecan-2 gene expression fell to 53 ± 12% of unstrained control at 24 hours (Figure 
14B). 
In addition to the comparisons just described, it was informative to determine if 
the magnitude of static strain influenced syndecan gene expression during any period of 
our investigation (Figure 15).    To determine this, interaction effects between static strain 
magnitude and duration of the two-way ANOVA data were examined.  This analysis 
identified no significant dependence of gene expression on the magnitude of static strain 
at any of the time points under investigation.  In other words, for each syndecan, gene 































































Figure 13. Effect of 5% static strain on syndecan-1 (A), syndecan-2 (B), and 
syndecan-4 (C) gene expression.  Human aortic SMCs were cultured on elastic 
membranes which were stretched at 1 Hz for the indicated periods of time.  The cells 
were then harvested, and RNA was isolated and analyzed using real-time PCR.  All 
results were internally normalized to 18S rRNA levels, and the syndecan levels are 
presented relative to unstrained controls.  The data represent the means and standard 
errors of triplicate experiments, and statistical analysis was performed using ANOVA, 
employing Holm-Sidak’s method for multiple pairwise comparisons.  (** Indicates a p 


























































Figure 14. Effect of 10% static strain on syndecan-1 (A), syndecan-2 (B), and 
syndecan-4 (C) gene expression.  Human aortic SMCs were cultured on elastic 
membranes which were stretched at 1 Hz for the indicated periods of time.  The cells 
were then harvested, and RNA was isolated and analyzed using real-time PCR.  All 
results were internally normalized to 18S rRNA levels, and the syndecan levels are 
presented relative to unstrained controls.  The data represent the means and standard 
errors of triplicate experiments, and statistical analysis was performed using ANOVA, 
employing Holm-Sidak’s method for multiple pairwise comparisons.  (** Indicates a p 








































































Figure 15. Effect of 5% (●) vs. 10% ( ) static strain on syndecan-1 (A), syndecan-2 
(B), and syndecan-4 (C) gene expression.  Human aortic SMCs were cultured on elastic 
membranes which were stretched at 1 Hz for the indicated periods of time.  The cells 
were then harvested, and RNA was isolated and analyzed using real-time PCR.  All 
results were normalized to endogenous 18S rRNA, and the syndecan levels are presented 
relative to unstrained controls.  The data represent the means and standard errors of 
triplicate experiments, and statistical analysis was performed using ANOVA.  2-way 




3.3.3 Cyclic Strain Regulates Syndecan Gene Expression in a Time-Dependent Manner 
Given the results from the static strain experiments, it was necessary to evaluate 
whether the pattern of syndecan expression suggested by the data was purely a stretch-
related event, or whether the periodic nature of cyclic strain was important.  We 
investigated whether the in vitro administration of cyclic strain influenced the kinetics of 
syndecan gene expression in vascular SMCs, and we found that the syndecans were again 
regulated differentially.  Under the application of 5% cyclic strain syndecan-4 gene 
expression exhibited a biphasic response (Figure 16C).  It increased significantly from 
119 ± 17% of unstrained controls at 1 hour to its peak of 200 ± 34% at 4 hours, and 
subsequently returned at 24 hours to the level of gene expression seen in the unstrained 
controls (121 ± 17%). 
In contrast to syndecan-4, syndecan-1 and syndecan-2 responded with steady 
increases in gene expression. Syndecan-1 displayed significant differences between 1 
hour and 24 hours and between 4 hours and 24 hours, increasing from 93 ± 6% of 
unstrained controls at 1 hour to 131 ± 14% at 4 hours to 206 ± 40% at 24 hours.  (Figure 
16A.  Syndecan-2  displayed significant increases between all three time points, 
increasing from 67 ± 7% of unstrained controls at 1 hour to 117 ± 8% at 4 hours, to 186 ± 
17% at 24 hours (Figure 16B). 
In order to assess the syndecan gene regulation under more chronic conditions, we 
chose to evaluate the response to cyclic strain of longer duration for the 10% studies.  In 
addition, the extra data points displayed in Figure 17 (25 and 28 hrs) correspond to the 
data points used for the subsequent preconditioning experiments.  We also chose 10% 
because of the physiologic relevance of this strain magnitude166.  Under the application of 
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10% cyclic strain the results suggested that each syndecan responded in a similar fashion 
to their response to 5% cyclic strain (Figure 17).  Syndecan-4, similar to 5% cyclic strain, 
significantly increased from 127 ± 19% of unstrained controls at 1 hour to its peak of 182 
± 17% at 4 hours.  The subsequent reduction in syndecan-4 gene expression to 99 ± 11% 
was significant, and was evident at 24 hours.  Moreover, the reduced expression levels 
remained evident at 48 hours (66 ± 12%).  Syndecan-1 increased significantly from 107 ± 
10% of unstrained controls at 1 hour to 278 ± 33% at 24 hours, and remained elevated at 
48 hours (294 ± 31%).  Similarly, syndecan-2 significantly increased from 97 ± 14% of 
unstrained controls at 1 hour to 204 ± 17% at 24 hours, and also remained elevated at 222 
± 43% at 48 hours. 
Similar to the analysis of the static data, it was important to determine if the 
magnitude of cyclic strain influenced syndecan gene expression at any time under 
investigation by examining the interaction effects between cyclic strain duration and 
magnitude (Figure 18).  Our findings in this regard were also similar to those of the static 
strain protocols; namely, with one exception, there were no significant differences 
between 5% and 10% cyclic strain for any of the syndecans.  The exception was 
syndecan-1 gene expression at 24 hours (Figure 18A), which exhibited a significant 
difference between 5% and 10% strain after 24 hours, indicating that the increase in 
syndecan-1 expression depended on both the magnitude and duration of cyclic strain. 
To further investigate the effects of strain magnitude on syndecan gene expression, 
we chose magnitudes in which vascular injury occurs.  Using a dose-response study, we 
subjected the cells to levels of cyclic strain ranging from 5% up to 20% for 4 hours 
(Figure 19).  The encouraging results from the earlier experiments which demonstrated a 
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significant syndecan-4 response at this time guided our decision.  Unfortunately, the 
results indicated that cyclic strain of this duration failed to yield significant differences at 
various levels of strain, even at magnitudes able to cause cell injury.  Possible 
conclusions from this are that (1) 4 hours of strain was not long enough for significant 
differences in gene expression to become evident, (2) the cells did not sense 20% strain 
as a condition that was significantly different than 5%, or (3) the increased membrane 
strain was ineffectively transmitted to the cells.  To investigate the possibility that the 
cellular response to 20% strain required longer than 4 hours, we conducted the 
experiments described below.  As described below, these protocols also included a period 
































































Figure 16. Effect of 5% cyclic strain on syndecan-1 (A), syndecan-2 (B), and 
syndecan-4 (C) gene expression.  Human aortic SMCs were cultured on elastic 
membranes which were stretched at 1 Hz for the indicated periods of time.  The cells 
were then harvested, and RNA was isolated and analyzed using real-time PCR.  All 
results were internally normalized to 18S rRNA levels, and the syndecan levels are 
presented relative to unstrained controls.  The data represent the means and standard 
errors of at least triplicate experiments, and when necessary, statistical analysis was 
performed on the data after logarithmic transformation.  ANOVA was then performed, 
employing Holm-Sidak’s method for multiple pairwise comparisons.  (** Indicates a p 





























































Figure 17. Effect of 10% cyclic strain on syndecan-1 (A), syndecan-2 (B), and 
syndecan-4 (C) gene expression.  Human aortic SMCs were cultured on elastic 
membranes which were stretched at 1 Hz for the indicated periods of time.  The cells 
were then harvested, and RNA was isolated and analyzed using real time PCR.  All 
results were internally normalized to 18S rRNA levels, and the syndecan levels are 
presented relative to unstrained controls.  The data represent the means and standard 
errors of at least triplicate experiments, and when necessary, statistical analysis was 
performed on the data after logarithmic transformation.  ANOVA was then performed, 
employing Holm-Sidak’s method for multiple pairwise comparisons.  (** Indicates a p 




































































Figure 18. Effect of 5% (●) vs. 10% ( ) cyclic strain on syndecan-1 (A), syndecan-2 
(B), and syndecan-4 (C) gene expression.  Human aortic SMCs were cultured on elastic 
membranes which were stretched at 1 Hz for the indicated periods of time.  The cells 
were then harvested, and RNA was isolated and analyzed using real-time PCR.  All 
results were normalized to endogenous 18S rRNA, and the syndecan levels are presented 
relative to unstrained controls.  The data represent the means and standard errors of at 
least triplicate experiments, and statistical analysis was performed using ANOVA, 
employing Holm-Sidak’s method for multiple pairwise comparisons.  († Indicates a p 




































































Figure 19. Dose response of cyclic strain on syndecan-1 (A), syndecan-2 (B), and 
syndecan-4 (C) gene expression.  Human aortic SMCs were cultured on elastic 
membranes which were stretched at 1 Hz for 4 hours at the indicated maximum strain 
amplitudes.  The cells were then harvested, and RNA was isolated and analyzed using 
real-time PCR.  All results were internally normalized to 18S rRNA levels, and the 
syndecan levels are presented relative to unstrained controls.  Data represent the means 
and standard errors of at least triplicate experiments, and statistical analysis was 




3.3.4 Preconditioning Exhibits Syndecan-Specific Gene Regulation 
Given the apparently greater dependence of syndecan gene expression on the 
duration, rather than magnitude, of cyclic strain, our investigations took two approaches.  
We examined (1) whether these responses were stable or transient, and (2) whether, after 
an adjustment or preconditioning period, strain magnitude would reveal itself as a 
significant factor in syndecan gene expression.  In other words, we sought to investigate 
if any possible effects of strain magnitude in the previous experiments were masked by 
the temporal nature of the responses to mechanical stimuli.  To accomplish these aims, 
we used a final set of strain protocols, in which the cells were subjected to cyclic strain 
preconditioning, followed by a 10% or 20% cyclic strain time-course evaluation.  The 
reason for this protocol was that SMCs in vivo exist in a mechanically dynamic 
oscillatory environment.  It would therefore follow that this type of environment, rather 
than static culture, should serve as the baseline for experimentation.  Our preconditioning 
experiments consisted of 24 hours of cyclic strain at a total magnitude of 10% strain, and 
this was followed by the presence or absence of a step increase of an additional 10% 
strain (20% total) for the indicated periods of time up to 24 hours. 
Figure 20 outlines the results of this study, comparing the gene expression of cells 
strained for various times following the preconditioning period.  The filled circles 
represent cells in which the step increase did not occur, while the open triangles represent 
cells in which the 10% step increase did occur.  For syndecan-4, the response in gene 
expression in the 1, 4, and 24 hours following the preconditioning period (Figure 20C) 
was similar to what was observed during the initial onset of cyclic strain (both 5% and 
10%; Figure 18C).  Namely, a significant initial increase in gene expression from 99 ± 
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11% of unstrained controls just after preconditioning to 181 ± 1% at 4 hours of 20% 
cyclic strain occurred, followed by a significant decrease to 78 ± 2% at 24 hours of 20% 
cyclic strain.  Meanwhile, there were no significant changes in syndecan-4 gene 
expression in the cells kept at 10% cyclic strain following the preconditioning period.  It 
was also noteworthy that after 4 hours of strain beyond the preconditioning period, the 
difference in syndecan-4 gene expression between cells remaining at 10% strain and 
those stepped up to 20% strain following the preconditioning period was significant. 
Like syndecan-4, the syndecan-1 gene response responded to the step increase in 
cyclic strain much like it did to the initial onset of cyclic strain (Figure 20A and Figure 
18A).  Upon increasing the strain magnitude to 20%, syndecan-1 gene expression during 
the 24 hours following the preconditioning period included a monotonic increase in gene 
expression over time.  Syndecan-1 levels significantly increased from 278 ± 18% of 
unstrained controls at end of the preconditioning period to 516 ± 55% after 24 hours of 
the 20% cyclic strain period.  During this same period of time, the syndecan-1 gene 
expression of cells kept at 10% cyclic strain remained constant, ranging from 277 ± 9% 
of unstrained controls to 299 ± 33%.  In fact, at 24 hours of strain beyond the 
preconditioning period, the difference between cells subjected to 10% vs. 20% strain 
following the preconditioning period was significant. 
Unlike the other syndecans, the gene expression of syndecan-2 was not 
significantly affected by a 10% step increase in strain magnitude following 
preconditioning (Figure 20B).  Whether the strain was maintained at 10% or stepped up 
to 20% cyclic strain following the preconditioning period, syndecan-2 gene expression 
varied only slightly.  Syndecan-2 expression in cells maintained at 10% cyclic strain 
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ranged from 204 ± 17% of unstrained controls to a maximum of 283 ± 17%.  In cells 
treated with a step increase of 10% additional strain, syndecan-2 gene expression 
likewise increased to only 254 ± 28% of unstrained controls. 
Taken together, the preconditioning results suggest that the cyclic strain-induced 
gene regulation of all three syndecans under investigation stabilized during the 
preconditioning period.  However, unlike syndecan-2, syndecan-1 and syndecan-4 
retained their ability to respond to a step increase in strain magnitude – each with its own 
characteristic response.  Syndecan-4, whose gene expression had returned to baseline by 
the end of the preconditioning period, showed an immediate response to the step increase 
in strain magnitude.  Syndecan-1, whose gene expression had reached an elevated plateau 
by the end of the preconditioning period, showed that it retained the capacity for a 




































































Figure 20. Effect of 24 hour preconditioning at 10% cyclic strain, followed by 10% 
(●) vs. 20% ( ) cyclic strain on syndecan-1 (A), syndecan-2 (B), and syndecan-4 (C) 
gene expression.  Human aortic SMCs were cultured on elastic membranes which were 
stretched at 1 Hz at 10% cyclic strain for 24 hours, followed by 20% cyclic strain for the 
indicated periods of time.  The cells were then harvested, and RNA was isolated and 
analyzed using real-time PCR.  All results were internally normalized to 18S rRNA, and 
the syndecan levels are presented relative to unstrained controls.  The data represent the 
means and standard errors of at least triplicate experiments, and when necessary, 
statistical analysis was performed on the data after logarithmic transformation.  ANOVA 
was then performed, employing Holm-Sidak’s method for multiple pairwise comparisons.  
(** Indicates a p value < 0.05 for comparisons with preconditioned cells.  † Indicates a p 





3.4.1 Perspective on the 2-Deminsional Strain Device 
As principal components of the mechanically dynamic vascular wall, SMCs in 
vivo are subject to forces which are poorly recapitulated in conventional cell culture.  
Unfortunately, the mechanical properties of three dimensional organ culture models of 
blood vessels are not well characterized, and the interactions of the different cell types 
confound potential results.  For this reason, we chose to employ the StrainMaster 
apparatus for our experiments.  Leung et al. and Meikle et al. were some of the first to 
quantitatively study the effect of tension on cells in vitro178,179, while Hasegawa et al. 
were the first to use a deformable circular substrate180.  Despite some limitations, this 
system has been well characterized by others, and was useful for examining the 
regulation of syndecan gene expression by specific mechanical stimuli.  The strain 
protocols in our experiments were chosen as in vitro approximations of physiologic 
conditions, and as such, the first requirement was that the cells remained viable for the 
duration of any given protocol.  We demonstrated that this requirement was met using a 
Live/Dead viability assay, in which negligible cell death occurred. 
 
3.4.2 Strain Assay Limitations 
One concern regarding the strain device used in our experiments, as described by 
Brown et al., was the presence of reactive fluid stress, which was induced by motion of 
the overlying nutrient medium181.  The components of this stress appeared in the form of 
normal (due to hydrostatic pressure and fluid vertical acceleration) and shear (due to fluid 
velocity gradients) stresses.  Although a potential limitation of our experiments was that 
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the biological significance of these stresses were not taken into account, Brown et al.’s 
analysis suggests that the effects were minimal for the particular strain device we used.  
Using finite element modeling, the authors found that for the StrainMaster apparatus, the 
reactive normal stress remained essentially constant during cyclic stretch.  On the other 
hand, for the Flexercell Unit, this stress varied throughout the duty cycle depending on 
the radial position.  Moreover, while the reactive shear stress for the Flexercell Unit was 
described as irregular, the StrainMaster apparatus displayed significant shear stress only 
at the circular lip region. 
Another potential limitation of the strain device was the heat generated by the 
friction of the membrane and platen sliding past each other, despite the use of lubricants.  
Though not likely to be a significant consideration in our current experiments, this 
phenomenon may become so in future experiments where strain magnitudes, and thus 
sliding distance, are increased. 
Admittedly, the robustness of any conclusions regarding the effects of strain 
magnitude required that any temporal effects be stabilized.  In other words, the 
experiments required that syndecan gene expression levels were at steady-state at the 
time in which any change in magnitude took place.  It was reasonable to assume that this 
requirement was met for the experiments in which this change in magnitude took place 
only at the start of the experiment.  However, in the preconditioning experiments, it was 
necessary to validate that the strained cells had reached a new steady-state by the end of 
the preconditioning period.  This was accomplished by examining syndecan gene 
expression in cells from parallel experiments – which were kept at the preconditioned 
magnitude for the duration of the experiment. 
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Conversely, conclusions regarding the effects of duration of strain required that 
the magnitude be held constant.  The strain device we chose to use was well suited to 
meet this requirement as far as membrane strain was concerned.  It has been validated to 
reproducibly impart a wide range of homogeneous and equibiaxial strains to an overlying 
membrane162,163.  Moreover, the silicone elastomer substrate exhibited stable elastic 
properties over the duration and range of temperatures used in our experiments.  Plastic 
deformation, fatigue, and viscoelastic properties such as stress relaxation and time 
dependence are potential considerations which were not significant attributes of the 
chosen system. 
Unfortunately, the requirement for constant strain magnitude was not necessarily 
maintained by the SMC monolayer, and our analysis did not take into consideration the 
biophysical mechanisms underlying the transmission of stresses between the silicone 
substrate and SMC membrane.  A potential limitation of our experimental system was 
that the silicone substrate strain was assumed to be equivalent to the cellular strain; 
however, the validity of this assumption required that at least two critical conditions be 
met.  The first condition was that the cells formed rigid and stable adhesive contacts with 
the underlying membrane.  The second was that the cells had negligible stiffness of their 
own.  As outlined below, neither of these conditions was necessarily true. 
 
3.4.3 Cellular Mechanics Considerations 
As discussed previously, cell adhesion is a complex process that occurs due to the 
interaction of various molecules, including syndecan63,64 and integrin receptors182,183.  
Adhesive contacts, or focal adhesions, that form between cells and the ECM undergo 
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dynamic assembly and disassembly.  Thus, they are neither stable nor completely rigid.  
They are widely regarded as receptor nodes that connect the cytoskeleton to the 
membrane and cytoplasm, and key aspects of their biological importance have been well 
characterized.  On the intracellular side, focal adhesions are linked to the cytoskeleton, 
which assembles and disassembles to varying degrees based on cell locomotion and 
division.  On the extracellular side, focal adhesions adhere to ECM glycoproteins, such as 
FN and vitronectin, which are often secreted by the cells themselves.  This multi-domain 
provisional matrix allows lateral mobility of the “cell anchors” based in part on the 
presence of rigid structural proteins, such as collagens.  Therefore, in our model system, 
the rigidity of the ECM, which is sandwiched between the silicone and cell membranes, 
itself contributes to mobility of the cell anchors.  In addition to these examples of 
receptor mobility, focal adhesions can be also endocytosed by the cell and recycled, 
eliminating the anchor altogether. 
The presence of dynamic and quantifiable cell stiffness makes the second 
condition fail as well.  In cellular mechanics, a full description of the stress on a cell 
incorporates the contributions from the ECM, focal adhesion complexes, the cytoskeleton, 
in addition to the area of the cell membrane in direct contact with an applied force.  
Though the actual physical deformations of adherent cells are difficult to theoretically 
characterize, several models attempting to describe the cell mechanical properties have 
been proposed, and one in particular has gained considerable support – tensegrity, or 
tensional integrity.   
 
3.4.4 Tensegrity and the Effect Cell Prestress on Membrane Strain 
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The idea of tensegrity was made popular by R. Buckminster Fuller184 as an 
architectural design principle, and has recently been championed in reference to cell 
biomechanics by Ingber185-194.  The theory suggests, among other things, that an 
externally-applied stress is transmitted by discrete molecular networks that extend 
through the cytoplasm, and this transmission depends on interactions between all three 
cytoskeletal filament systems – actin, intermediate, and microtubules.  It places an 
emphasis on hierarchical, rather than isolated systems, to explain cell behavior, and 
models the cytoskeleton as a prestressed framework composed of molecular struts, ropes, 
and cables.  This is in contrast to half-space models195-197 and theories which suggest that 
the stress is borne exclusively by the submembranous cortical actin layer198 of individual 
cells.  Internal tensile load/prestress, a fundamental feature of tensegrity, is believed to 
help stabilize cell shape, and this principle is useful in explaining what strains the cells in 
our experiments might actually experience.  The theory suggests that cell stiffness is a 
linear function of cell prestress199,200; the result of this increased stiffness in our 
experiments may have been decreased local cellular strain, leading to decreased stimulus 
for cellular responses.  Conversely, strain hardening is thought to mediate transduction of 
mechanical signals across the plasma membrane through the cytoskeleton201. 
Tensegrity is a useful tool for explaining various cellular processes.  For example, 
it has been shown in SMCs that tension on integrins leads to intracellular decompression 
of microtubules, resulting in compensatory polymerization202,203, and that cyclic strain 
results in increased stress fiber formation204,205.  In addition, others have shown that the 
cytoskeleton of adherent cells develops mechanical stresses that oppose distortions in cell 
shape15,187,193, that disruption of any of the three major cytoskeletal filament systems 
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results in a decrease in cell stiffness191, and that this stiffening is an active process, 
requiring both actin polymerization and myosin activation206.  Also, forces applied to 
integrins produce an increase in focal adhesion assembly in various cell types.  In fact, 
stress-activated signals transmitted by integrins are distinct from those due integrin 
receptor clustering alone.  The results of Xu have made this description more complex by 
demonstrating that the cytoskeleton can strain harden and strain soften, depending on the 
characteristics of the applied strain201.  He reconciled these findings by comparing the 
cytoskeleton with weakly-crosslinked polymer networks, which can easily slide past one 
another when strained slowly, but whose stiffness increases dramatically with increasing 
strain rate. 
The tensegrity theory also implicates a mechanism for the activation of 
mechanosensitive receptors and channels located in areas not in direct apposition with the 
underlying substrate.  Since information is often distributed among numerous pathways, 
potentially leading to many different responses, mechanosensors may be located on the 
apical surface or even the nuclear membrane.  In fact, both cell motility and cell cycle 
progression can be inhibited by either disruption of the actin cytoskeleton or inhibition of 
cytoskeletal tension generation.  Since the cells generate their own internal prestress in 
the actin cytoskeleton, balanced by internal microtubule struts and ECM adhesions, such 
mechanosensors could respond to signals from inside the cell, through their molecular 
linkages to the cytoskeleton. 
Together, when coupled with adhesive contacts with a flexible substrate, the 
processes that result in an increase in the cell’s internal prestress and resistance to global 
structural rearrangements are manifested as increased cell traction.  Overall, cell traction 
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results in relative compression of the silicone substrate underneath the cells and tension 
in the substrate elsewhere, leading to an effective compliance mismatch at different areas 
along the surface.  When the substrate is therefore subjected to a certain level of external 
strain, that strain is not transmitted uniformly over the entire surface, and since the cells 
have a higher elastic modulus than the silicone, the area not directly under the cells will 
need to deform to a greater extent in order for the substrate as a whole to achieve a given 
total strain. 
An added consequence of the non-uniform, position-dependent variations in 
substrate strain is that the compliance mismatch leads to local elevated strain, and 
therefore shear stress, gradients at the cell-substrate attachment points.  In part, this 
means that receptors at the cell periphery experience the maximum shear stress, while 
those closer to the centers of the cells experience much less.  These elevated shear forces 
are more likely to overcome the cell adhesive forces, ultimately resulting in sliding of the 
membrane relative to the cells.  In fact, these phenomena occur at the multicellular level 
as well as the single cell level.  As the SMC monolayer forms, and the cells create 
adhesive contacts with other cells as well as the substrate, cells at the periphery 
effectively shield those in the interior from the applied strain.  If the shear forces 
experienced by these cells overcome the cell adhesive forces, the result will be a 
redistribution of the forces over a smaller effective cell adhesion contact area. 
 
3.4.5 Syndecan Gene Expression Dependence on Strain Protocols 
Despite the failure to meet the two criteria mentioned above, we can draw 
important conclusions from the results obtained using the present strain device.  In the 
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studies described in this chapter, we characterized the regulation of syndecan-4 gene 
expression in vascular SMCs by various mechanical strain protocols.  In addition, we 
examined the similarities between syndecan-4 and two other syndecans expressed by our 
cell system – syndecan-1 and syndecan-2.  Analysis of syndecan expression in response 
to static strain served as a useful beginning for the study of the strain-induced gene 
regulation.  We found that this mechanical environment regulated syndecan-4 and 
syndecan-2 similarly.  Both genes displayed reduced expression at longer durations of 
static strain, while syndecan-1 seemed to be altogether unresponsive to static strain.  The 
static protocol was limited in that it modeled a small subset of the mechanical 
environments to which vascular SMCs are subjected.  Nonetheless, this strain regime was 
useful for modeling vascular mechanics during cardiopulmonary bypass153, and to a 
lesser extent PTCA and initial stent placement; however, modeling normal and 
pathologic hemodynamics required a cyclic model. 
When subjected to cyclic strain, the gene expression of all three syndecans was 
regulated in slightly different ways.  Syndecan-4 exhibited a bimodal response, 
increasing rapidly by 4 hours and then returning to or below baseline.  This response was 
conserved at various levels of strain magnitude.  Syndecan-1 and syndecan-2, on the 
other hand increased steadily over a 24 hour period, but then remained constant for the 
duration of the experiments.  It is noteworthy that syndecan-1 gene expression appeared 
to be responsive to both strain magnitude and duration.  As Figure 18A shows, 24 hour 
syndecan-1 gene expression was sensitive to the magnitude of cyclic strain, unlike the 
other syndecans.  This behavior of syndecan-1 gene expression correlated with the 
preconditioning data, in which syndecan-1 gene expression remained responsive to a step 
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increase in strain magnitude.  Combined, these data suggest that regulation of syndecan-1 
may be a critical component of the cellular response to chronic injury. 
The preconditioning results for both syndecan-4 and syndecan-1 were interesting 
because they demonstrated responsiveness to changes beyond the initial perturbation.  
Assuming that the 24 hour preconditioning period was of sufficient duration to allow the 
cells to reach steady-state, the baseline syndecan-4 gene expression seemed to be at the 
level of unstrained cells.  At the onset of a change in the mechanical environment, 
syndecan-4 gene expression quickly increased, but then rapidly returned to that baseline.  
Recent work in our lab has demonstrated that syndecan-4 RNA was regulated in a similar 
fashion by cyclic strain in a balloon angioplasty model164, and we have also previously 
shown evidence to suggest that syndecan-4 is an immediate early gene82.  Our current 
results further support the previous work and suggest either the presence of a strong 
negative feedback mechanism and/or a rapid exhaustion of a key component of this early 
response.  In other words, the mechanism by which the cells sensed the mechanical 
stimulus was rapidly activated, but then rapidly switched off and reset. 
Syndecan-1 gene expression, on the other hand, never returned to the unstrained 
baseline, within the time frame of our experiments.  As long as the mechanical stimulus 
was present, gene expression remained elevated.  Yet upon the step increase in strain 
magnitude, syndecan-1 gene expression increased above the newly-established 
preconditioned baseline, and did not return during the length of the experiment.  These 
findings seem to implicate a weak or nonexistent feedback mechanism and/or a large 
syndecan-1 genetic reserve.  In other words, syndecan-1 gene expression retained the 
capacity to be regulated beyond what was initially observed in the assay.  Under the 
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influence of an additional mechanical stimulus, additional syndecan-1 gene expression 
was available.  In light of the kinetics of the syndecan-1 response, one strain protocol that 
could help to clarify syndecan-1 regulation would be a dose response study of 5%, 10%, 
and 20% strain evaluated at 24 hours rather than 4 hours. 
The above findings underscore the importance of understanding syndecan gene 
regulation in vascular biology.  Syndecans, through their roles in cell-ECM adhesion, 
growth factor binding, protease activity, wound healing, and embryonic morphogenesis, 
serve as important transducers of mechanical stimuli.  In particular, by using defined 
cyclic and static strain protocols, we were able to gain a better appreciation of the 
characteristics of this gene regulation in the mechanically dynamic vessel wall.  The 
logical and necessary next step in our understanding of the regulation of syndecans will 
be the analysis of protein expression and ectodomain shedding in response to many of the 
above strain protocols.  Since the regulatory mechanisms that govern gene vs. protein 
expression are distinct, future experiments should be aimed at identifying and 
manipulating them.  The goals of such experiments would be to both alter and to 
understand the importance of syndecan protein expression in mechanically strained cells.  
The experiments described in the next chapter represent examples of such experiments, in 
which intracellular MAP kinase signaling pathways were targeted for their potential role 











CYCLIC STRAIN – INDUCED REGULATION OF SYNDECAN-4 PROTEIN IS 
INFLUENCED BY MAP KINASE ACTIVITY 
 
Given the results from the gene expression studies, we focused our interest on 
syndecan-4 protein regulation.  For various reasons the gene and protein expression 
patterns of a given protein often don’t correlate, and we became interested in one of these 
potential reasons in particular – MAP kinase signaling.  In fact, a body of evidence has 
accumulated linking certain intracellular signaling pathways to the regulation of both cell 
surface and the shed ectodomains of HSPGs.  Additionally, numerous reports have 
demonstrated that MAP kinase pathways are activated by mechanical stress149,207-209.  Our 
aim was to assess the influence of MAP kinase signaling on syndecan-4 expression and 
ectodomain shedding‡.  We postulated that, through the regulation of these key 
intracellular signaling events, mechanical strain modulates cell surface syndecan-4 levels, 
and therefore plays a pivotal role in vascular remodeling. 
 
4.1 Background and Significance 
4.1.1 Importance of MAP Kinase Signaling 
MAP kinases are a family of serine/threonine kinases intricately involved in the 
conduction and amplification of critical cellular signaling pathways.  The family includes 
ERK1/2, p38 MAP kinase, and c-Jun NH2-terminal kinase/stress-activated protein kinase 
(JNK/SAPK).  As a group, they are well-known to be activated in response to a variety of 
                                                 
‡ See Appendix B for supplemental syndecan-1 and syndecan-2 data 
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extracellular stimuli, and are commonly employed by cells to transmit extracellular 
signals into cellular responses, including proliferation, differentiation, apoptosis, and 
adaptation to external stress.  When initially discovered, these pathways were thought to 
be activated by distinct stimuli.  For example, ERK1/2 (also known as p44/42 MAP 
kinase) are a pair of 44 and 42 kD protein kinases that were classically thought to be 
involved with cellular responses to growth and neurotrophic factors210.  p38 MAP kinase 
is a 38 kD protein kinase that was thought to be involved in the cellular response to 
inflammatory cytokines and a variety of cellular stresses211.  JNK/SAPK, first described 
as UV-activated kinase, was initially shown to be involved in cellular responses similar to 
p38 MAP kinase, but it also appears to offer protection against apoptosis212,213.  More 
recently, ERK1/2 has been shown to be involved in the regulation of transcriptional and 
translational activation of a variety of proteins.  In addition, ERK1/2 signaling also 
occurs due to cellular stresses, such as heat shock, hyperosmolarity, oxidative stress, 
radiation, and ultraviolet (UV) light.  Cellular response to these stresses were initially 
thought to be mediated through JNK/SAPK and p38 MAP kinase signaling.  As a group, 
the MAP kinases represent key molecules in separate, but highly interconnected, 
phosphorylation cascades. 
We have previously determined that the ERK1/2 signaling pathway is involved in 
the up-regulation and shedding of syndecan-4 in response to oxidative stress214.  In 
addition, Fitzgerald et al. have demonstrated that metalloproteinase-dependent syndecan-
1 and syndecan-4 shedding involves selective MAP kinase activity215.  Specifically, 
ERK1/2 activity was found to be required for shedding induced by EGF and thrombin 
receptor activation, while p38 MAP kinase activity was not involved.  These authors also 
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demonstrated that cellular stress induced by hyperosmolarity or ceramide treatment 
trigger shedding via PKC-dependent pathways that are likely upstream of JNK/SAPK 
activation.  We therefore postulated that cyclic mechanical stress-induced activation of 
ERK1/2 and/or other MAP kinase signaling mechanisms results in the up-regulation of 
syndecan-4 expression and shedding. 
4.1.2 Syndecan Ectodomain Shedding 
Ectodomain shedding is common to many membrane-bound proteins, including 
cytokines, growth factors, and adhesion proteins216.  It has been shown to play an 
important role in various diseases, including rheumatoid arthritis (tumor necrosis factor 
alpha (TNFα) receptor), Alzheimer’s disease (β-APP), and some types of cancer (EGF 
receptor)217,218.  It is a means of releasing functionally intact effector molecules into the 
surrounding medium.  For example, shedding of syndecan-1 and syndecan-4 ectodomains 
has been shown to localize the KC chemokine to alveolar fluid, resulting in 
transepithelial neutrophil migration and eventual inflammation219. Shedding of syndecan-
1 and syndecan-4 ectodomains can also be enhanced by growth factors71, by cellular 
stress215, and by microbial virulence factors220, and by conditioned media from 
mechanically-strained cells.  Though the mechanism of syndecan-4 shedding is not yet 
fully understood, several proposed mechanisms exist71,219,220.  The aim of this study was 
to determine, through selective inhibition, if MAP kinase signaling is involved in 
syndecan-4 protein expression and shedding under the influence of mechanical strain. 
 
4.2 Materials and Methods 
4.2.1 Cell Culture 
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Clonetics normal human aortic SMCs, culture medium and supplements were 
obtained from Cambrex Bio Science, and the cells were sub-cultured using standard 
techniques.  SmGM-2 was prepared according to the supplier’s recommendations 
(SmBM, supplemented with 5% FBS, 500 µg/mL hEGF, 5 µg/mL insulin, 2 mg/mL 
hFGF, 50 µg/mL gentamycin, and 50 mg/mL amphotericin-B.  Cells were maintained in 
tissue culture-treated petri dishes at 37ºC, 5% CO2, and humidified atmosphere.  Growth 
medium was changed every two days, and the cells were passaged 1:4 when the dishes 
were 80% confluent, using 0.05% Trypsin / 0.53 mM EDTA.  Experiments were 
performed on cells between passages 6 and 10 using Quiescence medium, which 
consisted of SmBM supplemented with 0.5% FBS, 50 µg/mL gentamycin, and 50 mg/mL 
amphotericin-B. 
 
4.2.2 Mechanical Strain Application 
Strain dishes were assembled in the following manner: the bases of bottomless, 
custom-made plastic petri dishes were fitted with silicone membrane (0.5 inch thickness; 
40 Durometer).  The silicone served as a flexible growth area of the strain dishes.  For all 
experiments, 5 µg/mL human plasma FN in PBS was pre-adsorbed to the growth area for 
at least 8 hours at 4ºC, serving as a substrate for cell attachment.  The cells were then 
seeded onto the membranes, cultured to 80% confluence in SmGM-2, and then growth-
arrested for 24 hours in Quiescence medium.   
Depending on the experimental conditions, defined static or cyclic tension was 
applied to the cells using a StrainMaster apparatus.  Contacting surfaces of the membrane 
and strain device were lubricated with Dawn concentrated dishwashing liquid.  Static and 
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cyclic tensions were applied using a StrainMaster apparatus that allowed control over the 
frequency and amplitude of the radial and circumferential strains of the membrane and, 
and enabled the application of homogeneous and biaxially uniform strains over the entire 
growth area of the membrane. 
The protocol for the application of mechanical strain for subsequent protein 
analysis was slightly different than for the RNA analysis.  Following MAP kinase 
inhibitor pre-treatment (when appropriate), stretching (1 Hz, 10% cyclic strain) of the 
various samples commenced in a staggered fashion, based upon the total duration that 
each was to be strained (Figure 21).  Since all samples were harvested simultaneously, 
stretching of the 24 hour strain samples commenced immediately, whereas stretching of 
the 4  and 1 hour strain samples were commenced at t = 20 hours and 23 hours, 
respectively.  The reason for this protocol was so that, upon harvesting the cells, we could 
collect 24 hour shed protein from samples, whether or not the cells were stretched.  The 
only difference between the samples was the fraction of the 24 hour period in which the 
cells were stretched.  Unstrained controls were performed concurrently for all 
experiments. 
 
4.2.3 MAP Kinase Activation 
For the analysis of MAP kinase activation, cells were grown to 80% confluence in 
SmGM-2 and Quiesced for 24 hours.  They were then strained for the indicated time 
points and lysed using Laemmli sample buffer with 5% β-mercaptoethanol (Sigma-
Aldrich, St. Louis, MO).  Lysates were sonicated for 20 seconds to shear DNA and 
reduce viscosity, and then were boiled for 5 min, followed by centrifugation at 16,000 x g 
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for 5 min.  Proteins in the supernatants were resolved by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to 0.45 µm supported 
nitrocellulose (Bio-Rad).  The immunoblots were blocked for 1 hour at room temperature 
with 5% nonfat dry milk in 0.1% Tween-TBS (20 mM Tris-HCl, 137-150 mM NaCl) pH 
7.6, washed with 0.1% Tween-TBS, and labeled overnight at 4ºC with one of the anti-
MAP kinase or anti-phospho-MAP kinase primary antibodies (Cell Signaling Technology, 
Beverly, MA), diluted 1:1000 in 5% bovine serum albumin (BSA) in 0.1% Tween-TBS.  
This was followed by incubation with horseradish peroxidase anti-rabbit IgG (Cell 
Signaling Technology), diluted 1:2000 in blocking buffer for 1 hour at room temperature.  
The immunoblot was then developed using enhanced chemiluminescence, and the labeled 
proteins were detected using BioMax MR autoradiography film.  Levels of protein were 
quantified by densitometry using ONE-Dscan image analysis software. 
 
4.2.4 MAP Kinase Inhibition 
U0126 (Cell Signaling Technology), SB203580 (EMD Biosciences, San Diego, 
CA), and (L)-JNK Inhibitor 1 (EMD Biosciences) were used to inhibit the 
phosphorylation cascades of the MAP kinase family (Table 3).  U0126 is a selective 
inhibitor of MAP kinase kinase (MEK) 1 and 2 activation, which are upstream activators 
of ERK1 and ERK2.  SB203580 and (L)-JNKI1, on the other hand, act by directly 
inhibiting the activity of p38 MAP kinase and JNK/SAPK, respectively.  U0126 and 
SB203580 were reconstituted in dimethyl sulfoxide (DMSO; Sigma-Aldrich), and 
administered to the cells at a final concentration of 20 µM.  An equal volume of sterile 
DMSO was used as a vehicle control for the untreated cells.  (L)-JNKI1 was reconstituted 
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in H2O and administered to the cells at a final concentration of 2 µM.  An equal volume 
of sterile H2O was added to the untreated controls.  The inhibitors were added to the cells 
at the indicated concentrations for 30 minutes prior to the onset of the 24 hour 
experimental period (Figure 21).  This resulted in all samples receiving the inhibitor or 
control treatment for the same length of time, regardless of when the straining of the 
particular sample actually commenced.  Though possibly unnecessary, after 20 hours, an 
additional dose of each inhibitor at an empiric concentration equal to half the initial dose 
was administered to the cells.  This was done in order to account for degradation and/or 
metabolism of the initially applied dose.  The reasons that additional dose was equal to 
only half the initial dose were (1) that only 4 hours remained in the experiments, and (2) 
to avoid cytotoxic concentrations of the inhibitors that may not have undergone 
degradation.  
 
Table 3. Mitogen-activated protein kinases of interest and chemical inhibitors. 
 
MAP Kinase Inhibitor Concentration 
ERK1/2 MAP kinase U0126 20 µM 
p38 MAP kinase SB203580 20 µM 
JNK/SAPK (L)-JNK Inhibitor 1 2 µM 
 
 
4.2.5 Shed Proteoglycan Isolation and Quantification 
The following protocols were adapted from Reiland et al.221 and Rioux et al.222.  
After the cells were treated with one of the strain protocols, the conditioned medium was 
passed through a 0.2 µM membrane filter (Millipore, Billerica, MA) in order to remove 
detached cells and debris.  For shed syndecan-4 purification urea was added to bring the 
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final concentration to 4 M.  The media (15 mL) was first concentrated to 400 µL using a 
10,000 MWCO Amicon Ultra-15 Centrifugal Filter Unit.  The retentate was bound to a 
Vivapure Mini Diethylamine weak anion exchange column (Vivascience, Edgewood, 
NY) using an equilibration buffer (20 mM NaOAc pH 5, 4 M urea, 0.5% Triton X-100, 1 
mM EDTA, 1 mM Na2SO4, 200 mM NaCl).  Proteoglycans were then eluted using 100 
µL of the same buffer containing 1 M NaCl.  Using Bio-Spin 6 (Bio-Rad, Hercules, CA) 
gel filtration columns for buffer exchange, the samples were transferred to a reaction 
buffer containing 3 mM Ca(OAc)2, 10 mM EDTA, 10 mM HEPES pH 7.0, 0.1% Triton 
X-100, 10 mM NEM (Sigma-Aldrich), and protease inhibitors (200 µM 4-(2-
aminoethyl)benzenesulfonylfluoride (AEBSF),  160 nM aprotinin, 10 µM bestatin, 3 µM 
E-64, 4 µM leupeptin, and 2 µM pepstatin A)(EMD Biosciences). Total protein was 
quantified using the BCA method.  GAG chains were digested by combining 30 µL of 
each sample with 2 mU heparitinase and 8 mU chondroitinase ABC (P. vulgaris, EC 
4.2.2.4, Seikagaku America).  The samples were incubated for 4 hours at 37ºC, after 
which the samples were placed on ice and ready for analysis. 
For shed syndecan-4 detection, a Bio-Dot SF slot blot apparatus (Bio-Rad) was 
assembled by stacking two sheets of 0.45 µm Immobilon-P PVDF membrane (Millipore) 
on top of three sheets of Bio-Dot SF filter paper (Bio-Rad).  Conditioned media was 
diluted 1:10 in heparitinase buffer containing no Triton X-100, and was then applied 
directly to the membrane using vacuum filtration.  The membrane was blocked for 1 hour 
at room temperature in 5% nonfat dry milk in 0.04% Tween-TBS pH 7.4.  The 
immunoblot was then labeled overnight at 4ºC with anti-syndecan-4 mAb (antibody 8G3; 
provided by Dr. Guido David, K. U. Leuven, Belgium) diluted 1:2000 in 1% nonfat dry 
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milk in 0.04% Tween-TBS pH 7.4.  It was then washed in 0.04% Tween-TBS pH 7.4, 
followed by incubation with horseradish peroxidase anti-mouse IgG, diluted 1:5000 in 
blocking buffer for 1 hour.  The immunoblot was then developed using enhanced 
chemiluminescence, and the labeled protein was detected using BioMax MR 
autoradiography film.  Levels of protein were quantified by densitometry using ONE-
Dscan image analysis software. 
 
4.2.6 Cell-Associated Proteoglycan Isolation and Quantification 
For cell-associated syndecan-4 purification, the cells were washed twice with cold 
PBS, and then 500 µL of lysis buffer was added to them, containing 20 mM Tris-HCl pH 
7.4, 150 mM NaCl, 10 mM EDTA, 1% Triton X-100, and protease inhibitors.  Following 
a 15 minute incubation on ice, the cells were scraped from the plates and homogenized by 
passing several times through a 26G needle.  The cell lysates were centrifuged at 16,000 
x g for 15 min at 4ºC.  Urea was added to 350 µL of the resulting supernatants up to a 
final concentration of 4 M, and the lysate was bound to a Vivapure Mini Diethylamine 
weak anion exchange column using the same equilibration buffer as for the conditioned 
medium.  Proteoglycans were then eluted using 100 µL of the same buffer containing 1 
M NaCl.  Using Bio-Spin 6 gel filtration columns for buffer exchange, the samples were 
transferred to the same heparitinase reaction buffer, and the total protein was quantified 
using the BCA method.  GAG chains were digested by combining 30 µL of each sample 
with 2 mU heparitinase and 8 mU chondroitinase ABC.  The samples were incubated for 
4 hours at 37ºC, after which an equal volume of Laemmli sample buffer containing 5% β-
mercaptoethanol was added.  The samples were resolved by SDS-PAGE, and then were 
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transferred to a 0.45 µm Immobilon-P PVDF membrane.  The membrane was blocked 
and probed, and syndecan-4 was detected in the same manner as for shed syndecan-4. 
 
4.2.7 Statistics and Data Analysis 
Values are given as mean ± SEM.  Statistical analysis was performed using 
SigmaStat  3.0 software package.  ANOVA was employed, using the Holm-Sidak or 
Tukey tests for multiple pairwise comparisons among the treatments.  When applicable, 
logarithmic transformation of the data was necessary prior to statistical analysis in order 
for it to conform to the ANOVA assumptions.  A p value < 0.05 was considered 





Figure 21. Protocols for the application of mechanical strain for subsequent protein 
analysis.  For MAP kinase inhibitor studies, the cells were pre-treated for 30 minutes, 
and again at t = 19.5 hours for any given experiment.  Beginning at t = 0, stretching (1 Hz, 
10% cyclic strain) of the various samples commenced in a staggered fashion, based upon 
the total duration that each was to be strained.  Since all samples were harvested 
simultaneously, stretching of the 24 hour strain samples commenced immediately (A), 
whereas stretching of the 4 hour (B) and 1 hour (C) strain samples were commenced at t 
= 20 hours and 23 hours, respectively.  Unstrained controls (D) were performed 










4.3.1 Cyclic Strain Regulates Shed and Cell-Associated Syndecan Protein 
The StrainMaster device was again used to mechanically strain cells in order to 
gain insight into the influence of cyclic strain on syndecan-4 regulation.  For these 
experiments, the strain protocol we chose to employ was 10% cyclic strain, 1 Hz, for 
various periods of time.  This choice of strain protocol was based on work by others 
demonstrating the physiologic relevance of 10% cyclic strain on aortic SMCs158-161 and 
from the results from the previous chapter, in which we demonstrated that this level of 
strain was sufficient to observe significant changes in syndecan-4 gene expression.  This 
magnitude of strain was therefore an appropriate initial set-point for analysis of 
syndecan-4 protein regulation.   
Since HSPGs can be released from the membrane via ectodomain shedding, 
quantification required an analysis of two separate protein sub-populations – cell-
associated and shed.  Therefore, in our analysis of syndecan-4 protein expression, we 
measured the sub-populations independently.  The syndecan-4 gene expression data 
suggested that strain-induced regulation occurred within the initial 4 hours of strain.  In 
the current experiments, shed protein was observed by slot blotting of non-heparitinase-
digested samples (Figure 22).  The specificity of the antibody and its ability to detect a 
single band by Western blotting permitted this application of the antigen directly to the 
membrane without introducing error into the densitometry analysis.  The results 
demonstrated that shed protein levels increased significantly throughout the duration of 
stretch, ranging from 237 ± 57% of unstrained controls at 1 hour to 537 ± 109% at 24 
hours.  On the other hand, cell-associated syndecan-4 levels initially decreased to 38 ± 
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11% of controls at 1 hour, increased significantly to 181 ± 22% at 4 hours, and then 
significantly dropped again to 70 ± 6% at 24 hours.  Thus, the kinetics of the cell-
associated syndecan-4 response closely mimicked the gene expression data, suggesting 
that the immediate loss of total cell-associated syndecan-4, via shedding from the cell 
surface, was initially recovered by newly-synthesized syndecan-4 from existing RNA.  
The combination of increased gene expression and continued protein synthesis during the 
first 4 hours of strain likely resulted in the eventual elevation of syndecan-4 cell-
associated protein levels.  After that, gene expression dropped off, leading to the return of 
protein expression to basal levels. 
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Figure 22. Immunoblot (A) and densitometry (B and C) analyses demonstrating 
syndecan-4 protein expression and shedding in response to cyclic mechanical strain.  
Human aortic SMCs were cultured on elastic membranes and stretched for the indicated 
periods of time.  Cell-associated (■) or shed (■) protein was isolated and analyzed by 
Western or slot blot, respectively.  All syndecan protein levels are presented as raw 
densitometric data (B) or relative to unstrained controls (C).  Data represent the mean and 
standard errors from at least three independent experiments.  ANOVA was performed 
using Tukey’s (B) or Holm-Sidak’s (C) method of multiple pairwise comparisons.  (** 




Cyclic Strain – Induced Syndecan-4 Protein Regulation 
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4.3.2 Cyclic Strain Activates MAP Kinases 
With the observation that the syndecan-4 was regulated by cyclic mechanical 
strain, we investigated the signaling pathways involved in this process.  As stated earlier, 
the total pool of syndecan-4 consists of cell-associated and shed protein, and regulation of 
these sub-populations most likely occur via distinct mechanisms.  The intracellular events 
which take place as the cells regulate this protein under the influence of this mechanical 
strain have not been well described. 
We first examined, through Western immunoblotting of the total and 
phosphorylated kinases, whether the initiation of cyclic strain activated these signaling 
pathways.  In the presence of 10% cyclic strain, we found that all three MAP kinases 
were activated.  While the total ERK1/2 remained constant, the ratio of 
phosphorylated/total ERK1/2 increased to from 107% prior to strain to 246% at 30 
minutes, and remained elevated at 60 minutes (Figure 23).  Similarly, p38 MAP kinase 
was activated by cyclic strain.  The ratio of phosphorylated/total p38 increased from 8% 
prior to strain to 284% at 15 minutes.  Following this, phospho-p38 levels dropped, 
reaching 49% at 60 minutes (Figure 24).  Finally, JNK/SAPK was also activated by 
cyclic strain.  The ratio of phosphorylated/total JNK/SAPK increased from 6% prior to 
strain to 183% at 60 minutes, while the total JNK/SAPK levels remained constant (Figure 
25).  Given these results, we then tested the hypothesis that MAP kinase signaling 
influences syndecan-4 regulation.  We accomplished this by utilizing chemical inhibitors 
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Figure 23. Phosphorylation of ERK1/2 MAP kinase in response to cyclic mechanical 
strain.  Representative Western immunoblotting (A) and densitometry analysis (B) 
demonstrate time-dependent activation of ERK1/2 activation.  Human aortic SMCs were 
cultured on elastic membranes and subjected to cyclic mechanical strain for the indicated 
periods of time.  Cells were then lysed and proteins were resolved by SDS-PAGE and 
transferred a nitrocellulose membrane.  Detection was performed using antibodies to total 
and phospho-ERK1/2, followed by chemiluminescence and visualization on 
autoradiography film.  Levels of protein were quantified using image analysis software, 
and the data are presented as the ratio of the phosphorylated to the total cellular ERK1/2 
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Figure 24. Phosphorylation of p38 MAP kinase in response to cyclic mechanical 
strain.  Representative Western immunoblotting (A) and densitometry analysis (B) 
demonstrating time-dependent activation of p38 MAP kinase activation are shown.  
Human aortic SMCs were cultured on elastic membranes and subjected to cyclic 
mechanical strain for the indicated periods of time.  Cells were then lysed and proteins 
were resolved by SDS-PAGE and transferred to a nitrocellulose membrane.  Detection 
was performed using antibodies to total and phospho-p38, followed by 
chemiluminescence and visualization on autoradiography film.  Levels of protein were 
quantified using image analysis software, and the data are presented as the ratio of the 
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Figure 25. Phosphorylation of JNK/SAPK in response to cyclic mechanical strain.  
Representative Western immunoblotting (A) and densitometry analysis (B) 
demonstrating time-dependent activation of JNK/SAPK activation are shown.  Human 
aortic SMCs were cultured on elastic membranes and subjected to cyclic mechanical 
strain for the indicated periods of time.  Cells were then lysed and proteins were resolved 
by SDS-PAGE and transferred to a nitrocellulose membrane.  Detection was performed 
using antibodies to total and phospho-JNK/SAPK, followed by chemiluminescence and 
visualization on autoradiography film.  Levels of protein were quantified using image 
analysis software, and the data are presented as the ratio of the phosphorylated to the total 





4.3.3 MAP Kinase Inhibition Alters the Response of Cell-Associated Syndecan-4 to 
Cyclic Strain 
We first examined the strain-mediated regulation of total cell-associated 
syndecan-4, which consisted of both the intracellular and membrane-bound protein.  Shed 
syndecan-4 was separated from this fraction, by removal of the conditioned media and 
washing of the cell monolayer prior to cell lysis, and then saved for later analysis.  In 
order to examine if activation of the various MAP kinases influenced the regulation of 
cell-associated syndecan-4 protein, our strategy involved pre-treating the cells for 30 
minutes with 20 µM U0126 as an inhibitor of ERK1/2, 20 µM SB203580 as an inhibitor 
of p38 MAP kinase, or 2 µM JNKI1 as an inhibitor of JNK/SAPK‡.  The inhibitors 
U0126223 and SB203580224 have become well established tools for specifically inhibiting 
critical steps in their respective MAP kinase pathway.  The inhibitor JNKI1, on the other 
hand, has not been studied as widely; nevertheless, it has also been shown to have 
specific bioactivity212,213.  As an example, cells pre-treated with U0126 prior to 
stimulation with 15 or 30 minutes of 10% cyclic strain exhibited a decrease in the levels 
of phospho-ERK1/2, compared with untreated controls (Figure 26).  We therefore sought 
to examine the consequence of this loss of activation on syndecan-4 protein regulation. 
We first validated that the inhibitors were not cytotoxic at the concentrations used 
in our investigations, using a Live/Dead assay to assess cell viability/injury (Figure 27).  
The results demonstrate that no significant cell death occurred under the conditions used.  
We then measured the cell-associated syndecan-4 protein levels of cyclically strained 
                                                 
‡ For the MAP kinase studies the term ‘treatment’ refers to the administration of one of the MAP kinase 




cells treated with or without one of the MAP kinase inhibitors.  All data presented have 
been normalized to the unstrained, untreated controls.  For the various comparisons, 
interaction effects between inhibitor treatment and duration of cyclic strain of the two-
way ANOVA data were examined.  This analysis enabled us to identify treatment effects 
that were dependent upon the duration of strain. 
In cells pre-treated with U0126, we found a significant difference in cell-
associated syndecan-4 expression between treated and control cells at 24 hours (Figure 
28).  While cell-associated syndecan-4 levels in the untreated cells had fallen to 30 ± 9% 
of unstrained controls, the cells strained in the presence of U0126 only fell to 62 ± 16%.  
At the other time points, the regulation of cell-associated syndecan-4 was independent of 
U0126 treatment, and thus, ERK1/2 activity: in the unstrained controls and those strained 
for 4 hours, ERK1/2 inhibition caused a slight but insignificant decrease in cell-
associated syndecan-4.  Results were similar for cells pre-treated with SB203580 (Figure 
29).  In the unstrained controls and those strained for 4 hours, p38 inhibition actually 
caused a slight but insignificant increase in cell-associated syndecan-4, and while cell-
associated syndecan-4 levels in the untreated cells again fell to 30 ± 9% of unstrained 
controls, the presence of SB203580 resulted in a sustained level of cell-associated 
syndecan-4 protein at 24 hours (82 ± 23% of unstrained controls). 
Pre-treatment with JNKI1 uniquely affected cell-associated syndecan-4 regulation 
in two ways (Figure 30).  First, it resulted in a significant difference in cell-associated 
syndecan-4 expression between treated and control cells that was opposite of what was 
observed in the U0126 and SB203580 studies.  Second, its effects were observed at 4 
hours, considerably earlier than in the other studies.  Specifically, while cell-associated 
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syndecan-4 levels in the untreated cells rose to 165 ± 24% of unstrained controls, the 
cells treated with JNKI1 fell to 77 ± 15%.  In fact, in the presence of JNKI1, cell-
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Figure 26. Immunoblots demonstrating the inhibition of ERK1/2 MAP kinase 
activation in the presence of U0126.  Human aortic SMCs were cultured on elastic 
membranes and subjected to cyclic mechanical strain for the 15 or 60 minutes in the 
presence or absence of 20 µM U0126 in DMSO.  Cells were then lysed and proteins were 
resolved by SDS-PAGE and transferred to a nitrocellulose membrane.  Detection was 
performed using antibodies to total and phospho-ERK1/2, followed by 






Figure 27. SMC viability when exposed to MAP Kinase inhibitors.  Cell viability was 
determined after a 24 hour exposure to (A) 20 µM U0126, (B) 20 µM SB203580, or (C) 
2 µM (L)-JNKI1 by visualizing fluorescence generated after the administration of calcein 














































Figure 28. Effect of ERK1/2 MAP kinase inhibition on the 24 hour accumulation of 
cell-associated syndecan-4 protein due to cyclic mechanical strain.  ERK1/2 
inhibition was obtained by treatment with 20 µM U0126 (■) in DMSO for 30 minutes.  
Control cells (■) were treated with the same volume of DMSO vehicle.  Cells were 
subjected to 1 Hz cyclic strain for 0 to 24 hours.  As described in Methods, the initiation 
of cyclic strain was staggered so that all dishes were harvested simultaneously.  The cell-
associated fractions were lysed and then bound to a diethylamine anion exchange 
column; proteoglycans were eluted and GAG chains were digested with heparitinase and 
chondroitinase.  (A) Proteins were resolved by SDS-PAGE and electrophoretically 
transferred to a PVDF membrane.  Detection was performed using anti-syndecan-4 
primary and HRP-conjugated secondary antibodies, followed by enhanced 
chemiluminescence and visualization on autoradiography film.  Levels of protein were 
quantified by densitometry using image analysis software.  (B) Concentrations were 
normalized to the syndecan-4 expression of unstrained, untreated control cells.  Data 
represent the mean and standard errors from at least three independent experiments.  
After logarithmic transformation of the data in order to make the error variances 
independent of the means, statistical analysis was performed using ANOVA, employing 















































Figure 29. Effect of p38 MAP kinase inhibition on the 24 hour accumulation of cell-
associated syndecan-4 protein due to cyclic mechanical strain.  p38 MAP kinase 
inhibition was obtained by treatment with 20 µM SB203580 (■) in DMSO for 30 minutes.  
Control cells (■) were treated with the same volume of DMSO vehicle.  Cells were 
subjected to 1 Hz cyclic strain for 0 to 24 hours.  As described in Methods, the initiation 
of cyclic strain was staggered so that all dishes were harvested simultaneously.  The cell-
associated fractions were lysed and then bound to a diethylamine anion exchange 
column; proteoglycans were eluted and GAG chains were digested with heparitinase and 
chondroitinase.  (A) Proteins were resolved by SDS-PAGE and electrophoretically 
transferred to a PVDF membrane.  Detection was performed using anti-syndecan-4 
primary and HRP-conjugated secondary antibodies, followed by enhanced 
chemiluminescence and visualization on autoradiography film.  Levels of protein were 
quantified by densitometry using image analysis software.  (B) Concentrations were 
normalized to the syndecan-4 expression of unstrained, untreated control cells.  Data 
represent the mean and standard errors from at least three independent experiments.  
After logarithmic transformation of the data in order to make the error variances 
independent of the means, statistical analysis was performed using ANOVA, employing 















































Figure 30. Effect of JNK/SAPK inhibition on the 24 hour accumulation of cell-
associated syndecan-4 protein due to cyclic mechanical strain.  JNK/SAPK inhibition 
was obtained by treatment with 2 µM (L)-JNKI1 (■) for 30 minutes.  Control cells (■) 
were treated with the same volume of H2O vehicle.  Cells were subjected to 1 Hz cyclic 
strain for 0 to 24 hours.  As described in Methods, the initiation of cyclic strain was 
staggered so that all dishes were harvested simultaneously.  The cell-associated fractions 
were lysed and then bound to a diethylamine anion exchange column; proteoglycans were 
eluted and GAG chains were digested with heparitinase and chondroitinase.  (A) Proteins 
were resolved by SDS-PAGE and electrophoretically transferred to a PVDF membrane.  
Detection was performed using anti-syndecan-4 primary and HRP-conjugated secondary 
antibodies, followed by enhanced chemiluminescence and visualization on 
autoradiography film.  Levels of protein were quantified by densitometry using image 
analysis software.  (B) Concentrations were normalized to the syndecan-4 expression of 
unstrained, untreated control cells.  Data represent the mean and standard errors from at 
least three independent experiments.  After logarithmic transformation of the data in 
order to make the error variances independent of the means, statistical analysis was 
performed using ANOVA, employing Holm-Sidak’s method for multiple pairwise 






4.3.4 MAP Kinase Inhibition Alters the Cyclic Strain Induced Shedding of Syndecan-4 
The regulation of protein shedding is distinct from total protein expression, and 
although they are interrelated, they have distinct regulatory mechanisms217.  Our 
objective was to determine to what degree MAP kinase activation regulated strain-
induced syndecan-4 shedding.  Similar to the cell-associated syndecan-4 studies, our 
experimental strategy for MAP kinase inhibition was through the use of pharmacological 
inhibitors.  The analysis involved determining the 24 hour cumulative shedding of 
syndecan-4, during which the cells were strained for all, part, or none of the time.  For 
example, the experimental sample designated as 0 hour strain consisted of conditioned 
media collected after a 24 hour period during which cells were not subjected to cyclic 
strain.  Consequently, the sample consisted of constitutively-shed protein only.  All 
values were first normalized to the untreated, constitutive shedding controls, and 
interaction effects from the two-way ANOVA were examined as before.  At each time 
point, values for the treated samples were expressed as the percent change from the 
untreated controls.  In cells pre-treated with U0126, we found significant suppression of 
syndecan-4 shedding at both 4 and 24 hours (Figure 31).  After 4 hours of cyclic strain, 
shed levels were reduced to 12 ± 4% of unstrained controls by the presence of U0126, 
compared to 227% ± 42% in the untreated controls.  After 24 hours, the level shed 
syndecan-4 from the treated cells had increased to only 209 ± 66% of unstrained controls, 
significantly different than the 1,110 ± 376% increase observed in the untreated controls.  
It was also notable that the presence of U0126 also suppressed the levels of 
constitutively-shed syndecan-4.   
In contrast to the U0126 data, cells pre-treated with SB203580 demonstrated a 
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strain-induced increase in shed syndecan-4 that was not significantly affected by the 
inhibition of p38 (Figure 32).  Although there were marginal decreases at each time point 
in the study, it is only noteworthy that, similar to U0126 pre-treatment, the cells exhibited 
a slight decrease in constitutively-shed syndecan-4 in the presence of SB203580.  At 4 
hours, the shed levels had increased to 177 ± 68% of unstrained controls, while at 24 
hours, the levels had increased to 679 ± 263%.  Finally, pre-treatment with JNKI1 
reduced the shedding of syndecan-4 in a manner similar to U0126.  At 4 hours, shed 
levels were significantly reduced from 97 ± 28% of unstrained controls to 7 ± 3%, while 
at 24 hours, shed syndecan-4 was significantly reduced from 230 ± 49% of unstrained 
controls to 67 ± 23%.  Also similar to U0126, the presence of JNKI1 suppressed the 















































Figure 31. Effect of ERK1/2 MAP kinase inhibition on the 24 hour accumulation of 
shed syndecan-4 protein due to cyclic mechanical strain.  ERK1/2 inhibition was 
obtained by treatment with 20 µM U0126 (■) in DMSO for 30 minutes.  Control cells (■) 
were treated with the same volume of DMSO vehicle.  Cells were subjected to 1 Hz 
cyclic strain for 0 to 24 hours.  As described in Methods, the initiation of cyclic strain 
was staggered so that all dishes were harvested simultaneously.  The cell-free conditioned 
media were concentrated 30X and then bound to a diethylamine anion exchange column; 
proteoglycans were eluted, and the samples were applied directly to a PVDF membrane 
using a slot blot apparatus.  (A) Detection was performed using anti-syndecan-4 primary 
and HRP-conjugated secondary antibodies, followed by enhanced chemiluminescence 
and visualization on autoradiography film.  Levels of protein were quantified by 
densitometry using image analysis software.  (B) Concentrations were normalized to the 
syndecan-4 expression of unstrained, untreated control cells.  Data represent the mean 
and standard errors from at least three independent experiments.  After logarithmic 
transformation of the data in order to make the error variances independent of the means, 
statistical analysis was performed using ANOVA, employing Holm-Sidak’s method for 















































Figure 32. Effect of p38 MAP kinase inhibition on the 24 hour accumulation of shed 
syndecan-4 protein due to cyclic mechanical strain.  p38 MAP kinase inhibition was 
obtained by treatment with 20 µM SB203580 (■) in DMSO for 30 minutes.  Control cells 
(■) were treated with the same volume of DMSO vehicle.  Cells were subjected to 1 Hz 
cyclic strain for 0 to 24 hours.  As described in Methods, the initiation of cyclic strain 
was staggered so that all dishes were harvested simultaneously.  The cell-free conditioned 
media were concentrated 30X and then bound to a diethylamine anion exchange column; 
proteoglycans were eluted, and the samples were applied directly to a PVDF membrane 
using a slot blot apparatus.  (A) Detection was performed using anti-syndecan-4 primary 
and HRP-conjugated secondary antibodies, followed by enhanced chemiluminescence 
and visualization on autoradiography film.  Levels of protein were quantified by 
densitometry using image analysis software.  (B) Concentrations were normalized to the 
syndecan-4 expression of unstrained, untreated control cells.  Data represent the mean 
and standard errors from at least three independent experiments.  After logarithmic 
transformation of the data in order to make the error variances independent of the means, 
statistical analysis was performed using ANOVA, employing Holm-Sidak’s method for 

















































Figure 33. Effect of JNK/SAPK inhibition on the 24 hour accumulation of shed 
syndecan-4 protein due to cyclic mechanical strain.  JNK/SAPK inhibition was 
obtained by treatment with 2 µM (L)-JNKI1 (■) for 30 minutes.  Control cells (■) were 
treated with the same volume of H2O vehicle.  Cells were subjected to 1 Hz cyclic strain 
for 0 to 24 hours.  As described in Methods, the initiation of cyclic strain was staggered 
so that all dishes were harvested simultaneously.  The cell-free conditioned media were 
concentrated 30X and then bound to a diethylamine anion exchange column; 
proteoglycans were eluted, and the samples were applied directly to a PVDF membrane 
using a slot blot apparatus.  (A) Detection was performed using anti-syndecan-4 primary 
and HRP-conjugated secondary antibodies, followed by enhanced chemiluminescence 
and visualization on autoradiography film.  Levels of protein were quantified by 
densitometry using image analysis software.  (B) Concentrations were normalized to the 
syndecan-4 expression of unstrained, untreated control cells.  Data represent the mean 
and standard errors from at least three independent experiments.  After logarithmic 
transformation of the data in order to make the error variances independent of the means, 
statistical analysis was performed using ANOVA, employing Holm-Sidak’s method for 






4.4.1 Potential Mechanisms of Cell-Associated vs. Shed Syndecan Regulation 
Cells regulate expression and shedding of syndecans via complex mechanisms 
that are not completely understood, including gene expression, post-translational 
modification, and protein trafficking 215,225,226.  Because increased protein synthesis does 
not necessarily result in increased protein shedding, and vice versa, we elected to 
separately characterize the kinetics of both cell-associated and shed syndecan-4 protein 
expression in response of cyclic mechanical strain, and to examine the effect of MAP 
kinase signaling on these processes. 
Our studies demonstrated that 10% cyclic strain activated MAP kinase signaling.  
Through inhibition of specific enzymes in these signaling pathways, our results suggest 
that MAP kinase signaling played an important role in cyclic strain-induced syndecan-4 
regulation.  Specifically, all three MAP kinase pathways were involved in the strain-
induced regulation of cell-associated syndecan-4.  In particular, JNK/SAPK inhibition 
reduced the observed increase in cell-associated syndecan-4 that was typically seen after 
4 hours of cyclic strain.  Therefore, signaling via the JNK/SAPK pathway appeared to be 
required for the acute and transient increase in cell-associated syndecan-4.  Conversely, 
ERK1/2 and p38 MAP kinase inhibition reduced the observed decrease in cell associated 
syndecan that occurred after 24 hours of cyclic strain.  Therefore, ERK1/2 and p38 MAP 
kinase signaling pathways appeared to be responsible for the decrease in cell-associated 
syndecan-4 that was observed after prolonged periods of cyclic strain. 
On the other hand, ERK1/2 and JNK/SAPK inhibition reduced constitutive 
syndecan shedding and also appeared to limit accelerated shedding that occurred after 
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initiation of acute cyclic strain.  Signaling via the p38 MAP kinase pathway did not 
appear to be involved.  It is noteworthy that shedding in response to cyclic strain was not 
completely eliminated by U0126 and JNKI1, as evidenced by the increased shed 
syndecan-4 levels at 24 hours. This may have been due to either the action of cellular 
compensatory mechanisms or to the loss of activity of the inhibitors. 
While the cyclic strain-induced cell-associated syndecan-4 protein levels followed 
a pattern similar to the gene expression, shed levels continued to increase for the duration 
of the study.  There are several possible explanations for this.  As mentioned previously, 
the most direct correlation with syndecan-4 gene expression is with the regulation of the 
cell-associated fraction.  The levels of this fraction are governed by translation from 
newly synthesized and existing syndecan-4 RNA, syndecan-4 proteolysis, ectodomain 
shedding, as well as any positive and/or negative feedback controls due to accumulation 
or deprivation of products along the way.  All of these processes must be taken into 
consideration when attempting to fully characterize how cell-associated syndecan-4 is 
regulated.  Shed syndecan-4, on the other hand, is regulated by the newly synthesized and 
existing protein levels, trafficking to and deposition in the cell membrane, proteolytic 
cleavage of the ectodomains into the surrounding medium, as well as any feedback 
mechanisms. 
Given both the overlap and independence of the regulatory mechanisms, it was 
therefore difficult to conclude with certainty the causes of the differential effects of the 
MAP kinase inhibitors.  Despite this, our data most likely suggest that inhibition of 
ERK1/2 and JNK/SAPK had the primary effect of reducing syndecan-4 ectodomain 
shedding – both constitutive and cyclic strain-mediated, and we would speculate that this 
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effect was most likely through post-translational activation of a membrane protease.  This 
can explain why the shed syndecan-4 levels in the U0126 and JNKI1 pre-treated cells 
were significantly less than controls both constitutively and after 4 hours of cyclic strain.  
It could also explain why syndecan-4 levels in the U0126 pre-treated cells remained 
elevated at 24 hours; however, the reduced cellular levels in the JNKI1 pre-treated cells 
at 24 hours suggests that an additional and/or separate mechanism took place for this 
MAP kinase.  Additionally, the persistent elevation of cell-associated syndecan-4 by p38 
MAP kinase inhibition, in the absence of an appreciable effect on shed levels, suggests 
that p38 MAP kinase signaling was involved in the reduction of cell-associated syndecan-
4 under chronic cyclic strain.  It would appear that this was due to a reduction in 
syndecan-4 protein synthesis, rather than due to an effect on shedding.  In other words, 
the chronic stress-induced reduction in syndecan-4 occurred at least in part via a p38 
MAP kinase-dependent mechanism. 
Candidate targets for MAP kinase-dependent regulation of syndecan-4 shedding 
include the zinc-dependent, hydroxamate-sensitive metalloproteinases (MMPs).  In 
particular, the soluble, membrane-type MMP (MT-MMP) and ADAM families of cell-
associated proteases/secretases have been shown to have diverse biological activity, 
including important roles in ectodomain shedding, cell adhesion, tumor metastasis, 
wound healing, and atherogenesis216,218,227-235.  MT-MMPs are a subset of MMPs that are 
anchored to the cell membrane via either a transmembrane domain or a GPI anchor, 
while the typical multifunctional ADAM contains discrete pro-, metalloprotease, 
disintegrin-like, cysteine-rich, epidermal growth factor-like repeat, transmembrane, and 
cytoplasmic tail domains.  While MMPs and MT-MMPs act strictly as proteases, the 
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various domains confer on ADAMs the ability both to promote cell-cell / cell-ECM 
adhesion and to induce ectodomain shedding of several important bioactive 
molecules107,236.  Some of these shed molecules include syndecans, L-selectin, 
intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-
1), TGFα, β-amyloid precursor protein (APP), angiotensin converting enzyme (ACE), 
and they have been shown to be controlled by MAP kinase-dependent and independent 
mechanisms215,237-241.  Prior reports from our lab and others have demonstrated that 
syndecan shedding is regulated by a variety of stimuli, including extracellular 
ligands71,225, bacterial virulence factors220,242, and stress214,219.  However, only a select 
subset of these stimuli have been shown to act via MAP kinase signaling.  In particular, 
ERK1/2 and PKC signaling have been shown to be required for RANTES-induced 
shedding of syndecan-1 and syndecan-4 in HeLa cells241 and for EGF and thrombin 
receptor-induced shedding in mouse epithelial cells215.  Most other reports on the 
mechanism of syndecan shedding have focused on the involvement of intracellular 
tyrosine kinase243 and MMP219,226,229 activity on this process.  Furthermore, work by 
Sumpio and others investigating the role of cyclic strain-induced intracellular signaling 
activity on various vascular cell processes244,245, including SMC alignment and 
proliferation155,157,165,  has not addressed the circumstances surrounding ectodomain 
shedding.  However, given the body of published evidence, as well as our current data, it 
is likely that the mechanism of cyclic strain-induced shedding contains some of the same 
mediators as agonist-induced shedding.  In particular, it is also likely that MAP kinases 
are regulators of metalloproteinase activity.  Overall, this field is lacking a 
comprehensive description of the multi-step process of cyclic mechanical strain detection, 
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intracellular signaling, and subsequent syndecan shedding regulation.  For this reason, 
our results serve as an important contribution to this area, and it will be exciting to 
uncover the methods in which this modulation of cell-associated and shed syndecan-4 
levels affects the ability of the cells to adapt to cyclic strain. 
 
4.4.2 Limitations of Pharmacological Blockade of MAP Kinase Signaling 
Part of the uncertainty in the above conclusions stems from the target assay 
system.  Though extensively studied246-248, the MAP kinase pathways are highly 
regulated and interconnected, which has made experimental design difficult and hindered 
the development of solid conclusions.  Each cascade involves sequential activation of at 
least five levels of protein kinases, and each is usually initiated by transmission of signals 
from growth factor or tyrosine kinase receptors via members of the Rho family of small 
GTP-binding proteins.  The ERK1/2 pathway, classically associated with transmitting 
signals leading to cell proliferation and differentiation, is typically initiated by activation 
of receptor tyrosine kinases (RTKs), such as EGF receptor, by binding one of its ligands.  
This leads to activation of the small G-protein Ras, then membrane translocation and 
activation of Raf, dual phosphorylation of MEK1/2, and then threonine and tyrosine 
phosphorylation of ERK1/2.  ERK1/2 can then phosphorylate cytosolic targets such as 
MAP kinase-activated kinase (MAPKAPK), phospholipase A2 and RSK or can 
translocate to the nucleus to activate transcription factors such as Elk-1 and c-Myc.  
These transcription factors ultimately bind to the promoter sequences of specific genes to 
regulate gene expression.  Many of these same steps occur also when this pathway is 
activated by calcium influx or integrin activation.  It is noteworthy that, due to its 
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involvement in cell proliferation, the activity of this pathway has been associated with 
oncogenic transformation. 
The p38 MAP kinase and JNK/SAPK pathways, collectively known as the SAPK 
pathways249, each share some similarities to the canonical ERK1/2 model.  For example, 
each of the three pathways involves the sequential phosphorylation of kinases that are 
structurally and functionally similar to corresponding kinases in the other two pathways.  
In fact, similar to ERK1 and ERK2, the chief kinases of these two pathways also exist in 
several isoforms – JNK1/2 and p38α, β, and γ250.  In addition, the p38 MAP kinase and 
JNK/SAPK pathways can be initiated by RTK activation.  However, each of the SAPK 
pathways is activated in response to a unique but overlapping set of stimuli.  For p38 
MAP kinase, this set consists of inflammatory cytokines (such as TNFα) and Fas ligand 
binding to the TNFα receptor, oxidative stress, and UV irradiation.  Conversely, the 
JNK/SAPK pathway has been shown to be activated by growth factor binding, UV and γ 
irradiation, mechanical and oxidative stress, chemotherapeutic agents, activation of G-
protein-associated receptors, as well as inflammatory cytokine and Fas ligand binding to 
the TNFα receptor.  Activation of the p38 MAP kinase pathway, and subsequent 
activation of MAPKAPKs or phosphorylation of various transcription factors, including 
ATF-2 and Sap-1a, leads to cellular responses that include cytokine production and 
apoptosis.  Similarly, activation of the JNK pathway, and subsequent activation of 
transcription factors c-Jun, ATF-2, Elk-1, and p53, leads to growth, differentiation, 
adaptation, and apoptosis.  Indeed, the cellular response ultimately depends on the 
context and associated factors in which these pathways proceed. 
Despite the complexity of these pathways, the inhibitors used in this study were 
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useful tools; however, when investigating such a group of closely-related mechanisms, 
the studies were limited by the specificity of the given target.  In other words, the 
inhibitor of a specific enzyme in a given MAP kinase pathway was only useful to the 
extent that it didn’t interact with similar enzymes of a different pathway.  Unfortunately, 
this loss of specificity has been shown by others to occur in a dose-dependent manner.  
Additionally, a potential weakness of these studies is the considerable overlap of the 
pathways.  Since many of the key molecular targets are activated as part of multiple 
pathways, they allow for the existence of accessory paths toward the activation of a given 
end target.  It is possible that, due to this redundancy, the inhibitors used were not as 
specific as required for detailed analysis.  Lastly, the compounds used for pharmacologic 
inhibition offer experimental challenges.  For example, they often suffer from limited 
stability in culture.  Another problem is that some only offer competitive inhibition.  
Additionally, due to the particular solubility profile, control experiments require the use 
of potentially cell-stimulatory or cytotoxic solvents.  For example, U0126 and SB203580 
required the use dimethyl sulfoxide, while JNKI1 was soluble in water.  This may be an 
explanation for the different trends seen in the shed syndecan-4 levels when no inhibitor 
was present. Some alternatives to the use of pharmacological inhibitors include dominant 
negative mutants and antisense constructs207,251,252 in order to compete with or inhibit the 
native bioactive molecule.  In addition, the collective analysis of singular and 
multifactorial approaches, in which several targets are blocked at once, is required for a 
more comprehensive description. 
 
4.4.3 Functional Consequences of Altered Syndecan Expression 
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In summary, the cyclic strain-induced alteration of both the cell-associated and 
shed syndecan-4 is likely the result of the interaction of several mechanisms, of which 
only a small sampling was investigated in these studies.  Furthermore, the true behavior 
of vascular SMCs in the native artery is unique to the structural environment of the 
surrounding tissue.  Nevertheless, the functional consequences of altered syndecan-4 
expression involve those related to the quantity present on the cell membrane and the 
levels present as soluble effector molecules in the surrounding interstitium.  Since the 
shed ectodomains are released intact from the cell membrane, they can compete with 
remaining cell surface syndecans for ligand binding.  This involves interactions with the 
vast array of heparin-binding proteins, including ECM proteins, growth factors, cytokines, 
proteases/protease inhibitors, and adhesion molecules.  Depending on the normal cellular 
response to the interaction with the specific ligand, the presence of the newly shed, 
competing HS-containing ligands will abrogate that response.  Alternatively, heparin-
binding proteins whose activity is altered by their interaction with heparin and HSPGs 
will be able to attain this activity level without needing to be in proximity to cells.  
Wound fluids are examples of such cell-depleted environments.  Another consequence 
results from the sequestration of growth factors and cytokines, leading to cell chemotaxis 
toward a specific area, which may be necessary for the effective resolution of tissue 
damage. 
Alterations in the cell-associated syndecan-4 expression will also have a variety 
of consequences.  Due to its involvement in the development of focal adhesions and 
stress fibers along with β1 or β3 integrins, an up-regulation of cell-associated (and 
assuming membrane-bound) syndecan-4 will likely lead to the formation of a higher 
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density of, and thus stronger in aggregate, adhesions to the appropriate substrate.  Up-
regulation and aggregation of intact, membrane-bound syndecan-4 molecules will also 
result in increased cytoskeletal organization via intracellular adaptor proteins, such as 
vinculin, talin, paxillin, and others.  In addition, the syndecan-4-mediated increase in 
PKCα and possibly RhoA activity, as well as mechanotransduction via FAK signaling, 
will all lead to increased downstream cellular activity.  Revisiting the tensegrity theory 
from the previous chapter, the increased cytoskeletal organization in particular will likely 
lead to increased cell stiffness and cell traction when the cells are stretched.  Of course, 
the consequence over time would be negative feedback due to the apparent reduction in 
the cellular strain and therefore a decreased stimulus for continued syndecan-4 gene and 
protein synthesis. 
As an example, the response of SMCs to both hypertension-induced 
arteriosclerosis and angioplasty-induced restenosis involves cell proliferation, migration, 
and MAP kinase activation253.  It is likely that the initial response to the increased 
mechanical stress involves syndecan-4 proteolytic ectodomain shedding from the cell 
surface.  The subsequent liberation from adhesions allows the cells to proliferate, migrate, 
and secrete ECM components (in addition to the shed ectodomains) in such a way as to 
increase the thickness of and ultimately restore the initial stress in the vascular wall.  
Over time, recovery of the cell-surface syndecan-4 levels, focal adhesions, and 
cytoskeletal assembly will allow the cells to re-stabilize in a manner better suited to 





CONCLUSIONS AND FUTURE DIRECTIONS 
 
The studies described in this dissertation provide a framework for exploring more 
fully the role of syndecans in vascular biology and the pathogenesis of diseases 
precipitated by mechanical insult.  Like any framework, the interconnectedness of the 
structure as a whole is what makes it attractive and creates room for further exploration.  
In addition, many gaps require filling before the structure can be considered complete, 
and its strength ultimately relies on the foundation upon which its anchors place the 
greatest deal of weight.  To that effect, the experiments described here were motivated by 
recent work of others describing the fundamental biology of syndecans and their various 
roles in cellular function, and the elucidation of various regulatory steps and signaling 
mechanisms has fueled the current interest.  Additionally, the appreciation of and ability 
to manipulate the local cellular mechanical environment using engineering approaches 
have provided valuable insight into syndecan function. 
In the present study, we employed a device capable of exerting equibiaxial strain 
to an elastic membrane, and have reported that the application of mechanical strain 
regulates the gene expression of syndecan-1, syndecan-2, and syndecan-4 in a time-
dependent manner.  In light of the kinetics of the syndecan-1 gene response, one strain 
protocol that could help to clarify syndecan-1 regulation would be a dose response study 
of 5%, 10%, and 20% strain evaluated at 24 hours or longer.  The 4 hour time point was 
chosen because of the preliminary syndecan-4 data; however, the syndecan-1 data now 
suggest that longer times may yield important findings as well.   While earlier evidence 
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has indicated that syndecan-4 is an early response gene in vascular injury164,254, we have 
demonstrated that SMCs also regulate expression of these syndecans differentially based 
on whether the strain is static or cyclic.  In future experiments, various design 
considerations could be explored.  For example, it would be useful to apply strain in a 
defined, but anisotropic manner.  Given the tendency of vascular SMC to orient 
themselves based on the direction of strain, we would expect cell orientation, and 
possibly function, to depend on the characteristics of the strain field.  In addition, 
independent variations in frequency, duty cycle, and strain rate would provide additional 
stimuli.  Frequency manipulation would allow for the modeling of certain arrhythmias 
due to anemia or hormones.  On the other hand, strain rate manipulation would allow for 
the administration of a more physiologic (rather than sinusoidal) waveform to the cells. 
Future experiments could also explore the relationship between membrane and 
cellular strain.  In reference to the earlier discussion, the existence of cell prestress and 
strain hardening make methods of determining strain-induced cell stiffness important.  A 
reasonable method would be to microscopically visualize (using fluorescent probes for 
example) and compare the magnitude of strain at different points on the elastic membrane 
before and after cells have adhered, and at certain time points during a given cyclic strain 
protocol.  This would identify regions of non-homogeneity, and the analysis would 
provide a description and location of strain gradients.  These areas might ultimately prove 
to be foci of characteristic cellular activity.  For example, others have demonstrated a role 
for α-actinin-dependent crosslinking of F-actin networks, integrin binding and 
aggregation in strain hardening phenomena in vitro and in vivo199,201,255. 
The duration of cyclic strain is another potential area of investigation.  
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Experiments in which SMCs have been strained for more than a week have identified 
increased actin filament organization, focal adhesion formation, and cell stiffness204,205.  
Along with those employing an increased duration of cyclic strain, experiments could be 
performed in which markers of cell injury, such as lactate dehydrogenase or DNA 
leakage assays, are analyzed. 
We also investigated the strain-mediated expression of cell-associated and shed 
syndecan-4, and some of the intracellular signaling mechanisms involved in this process.  
These studies were inspired by the work of various others, who have studied signal 
transduction pathways in response to cyclic strain, and who provided persuasive evidence 
that cyclic strain rapidly activates MAP kinases.  Their work suggested that MAP kinases 
were important transducers of mechanical stress-induced responses of multiple cell types, 
including SMCs.  In our experiments, we targeted the signaling pathways of ERK1/2, a 
pair of 44 and 42 kD protein kinases involved with cellular response to growth factors210, 
p38 MAP kinase, a 38 kD protein kinase involved in the cellular response to 
inflammatory cytokines and endotoxins211, and JNK/SAPK, a pair of 54 and 46 kD 
protein kinases involved in cellular responses to UV radiation and heat shock212,213.  We 
found that MAP kinase signaling is required for the normal response to mechanical strain.  
In particular, ectodomain shedding was diminished in the absence of intact ERK1/2 and 
JNK/SAPK pathways. 
In addition to examining the cell-associated and shed protein levels of the other 
syndecans in response to the previously described conditions, the use of genetic knockout 
models of the various syndecans could serve as useful tools for comparing the 
requirement for the various syndecan functions in the response to different stress, such as 
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hypoxia and septic shock.  For example, current work in our lab is aimed at using one 
such model to characterize the involvement of syndecan-4 in atherogenesis.  Using these 
models, in combination with selective re-introduction of certain syndecan functions, such 
as stress fiber formation, PKCα signaling, and growth factor and other ligand 
sequestration, could provide significant insight into syndecan function under certain 
pathophysiologic conditions. 
Since the mechanism of syndecan shedding is unknown, this represents an area 
with great potential for additional experiments.  Some could include the use of potential 
alternative mediators of shedding, or inhibitors of known sheddases, in order determine if 
the same or similar cellular responses occur.  Alternatively, the use of other inhibitors of 
the MAP kinase pathway, such as retinoids and certain steroid hormones256,257, or even 
certain phosphatases could aid in clarifying the steps involved.  Protein kinase inhibitors 
such as genistein and tyrphostin are additional tools that could be used to further 
characterize strain-mediated syndecan shedding. 
Since vascular remodeling requires the coordinated interaction between cell 
surface adhesion molecules and the ECM, important adaptive cellular changes take place 
in response to a variety of external signals, including mechanical stress.  One critical 
event induced by a change in mechanical environment is altered cell locomotion with a 
presumed change in cell-matrix interactions, including cell-substrate adhesive forces. 
Since syndecan-4 has been implicated in cell-ECM adhesive interactions, we postulated 
that mechanical forces could mediate remodeling-related cell behavior through an effect 
on syndecan-4 expression.  The glass microsphere adhesion assay described in these 
studies proved to be a sensitive and effective means of quantifying cell-matrix 
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interactions of well spread cells.  Due to the importance of cell adhesion to engineered 
surfaces in tissue engineered vascular graft development, our studies allowed us to 
examine the effect of syndecan-4 regulation on a critical functional characteristic of 
SMCs.  In future endeavors, this assay offers the advantage of simplicity and adaptability, 
due to the range of forces and substrates that can be evaluated with different cell types 
and under various experimental conditions.  A future step could be to quantify the 
changes in adhesive strength of cells after subjecting them to cyclic mechanical strain; 
however, since the adhesion assay requires a rigid support substrate, it is unfortunately 
incompatible with the current cyclic strain set-up. 
The studies describes here also utilized an adenoviral vector system as a means of 
genetically modifying the cells of interest.  Despite its advantages over a number of other 
gene targeting methods, viral transduction systems such as this are labor intensive and 
suffer from some degree of variability.  As promising, more novel, technologies become 
established in our lab, such as RNA Interference (RNAi), which utilizes short interfering 
RNA (siRNA), as a means of specifically silencing gene transcripts, we may have the 
ability to circumvent some of the problems inherent in the current transfection and 
knockout strategies. 
Further experimentation could be also aimed at targeting syndecan-4 protein 
levels and characterizing its role in adhesion formation.  It is very likely that regulation of 
expression, trafficking, post-translational modification such as sulfation and acetylation, 
and ectodomain shedding may influence adhesion in a manner distinct from the effects of 
gene regulation.  Since cell adhesion involves a coordinated cascade of biochemical and 
biophysical events, modulation of both its magnitude and kinetics is likely to involve 
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several overlapping processes.  Furthermore, when relating cell-associated syndecan-4 
regulation with its functional consequences on cell adhesion, the cell surface syndecan-4 
levels (determined by FACS analysis or enzyme-linked immunosorbent assay (ELISA)), 
is likely to correlate better. 
Armed with an understanding of the role of syndecan-4 in these and other 
reparative vascular events, the goal of our investigations was to contribute to the 
foundational knowledge that will facilitate the development of rational treatment options 
for adhesion-dependent pathologic processes, including fibroproliferative disorders and 
cancer metastasis, as well as post-injury restenosis in blood vessels.  We are confident 
that a more detailed understanding of strain-induced molecular events, and the ability of 
cells to interact through mechanochemical signals via the syndecan family of HSPG 
receptors, will allow us to gain a greater insight into the mechanisms underlying cellular 
attachment and the extent of matrix remodeling.  The results from these studies offer 
methods of enhancing matrix stability in situations such as engineering cardiovascular 
tissue equivalents and enhancing atherosclerotic plaque stability.  The negative impact 
that cardiovascular disease has on health in the United States is enormous, and treatment 
options may eventually include cell cycle regulation of SMCs, syndecan-specific 
pharmacologic blockade, or manipulation of downstream signaling events.  These efforts 
would seek to inhibit cellular recognition and/or response to such events as the 
mechanical strain inflicted by balloon angioplasty or stent implantation.  In addition, 
enhancement of matrix stability by augmenting the cellular responses to mechanical 
stimuli, in conjunction with preconditioning, is a promising method in which to construct 
durable vascular grafts.  Thus, the rationale for future experimentation is that mechanical 
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strain is an impetus for, and HSPGs are critical mediators of, matrix-driven cell adhesive, 




MODELING THE MODIFIED CENTRIFUGATION ASSAY117 
 
A.1 Materials and Methods 
A.1.1 Cell culture 
PAC-1 immortalized rat pulmonary artery SMCs were provided by Dr. Abraham 
Rothman.  Though immortalized, these cells retain expression of important markers of 
SMC phenotype, including angiotensin II, norepinephrine, and α-thrombin receptors, and 
also SMC isoforms of α-actin, myosin heavy and regulatory light chains, α-tropomyosin, 
meta-vinculin, phosphoglucomutase, and calponin115.  The cells were cultured using 
standard cell culture techniques.  Growth medium consisted of M199 Medium, 
supplemented with 10% FBS, L-glutamine, 100 U/L penicillin, 100 µg/L streptomycin, 
and 10 U/L amphotericin B.  Quiescence medium consisted of growth medium, 
supplemented with 0.5% FBS.  Cells were incubated at 37ºC, 5% CO2, in a humidified 
atmosphere. 
 
A.1.2 Surface Adsorption 
The relationship between bulk solution and surface concentrations of heparin-
binding peptides was quantified by radiolabeling the peptides with 125I and adsorbing 
different concentrations to the surfaces of glass beads.  The tyrosine-containing peptides 
were radiolabeled using IODO-Beads Iodination Reagent according to the manufacturer’s 
instructions.  Briefly, 1 mCi Na125I per 100 µg target protein was oxidized and 
incorporated into the protein, using PBS pH 7.2 as the reaction buffer.  The reaction was 
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terminated by removing the beads from the mixture.  Unincorporated 125I was removed 
using a D-Salt Desalting Column (Pierce).  The protein was precipitated by incubation in 
10% trichloroacetic acid (TCA) for 45 minutes, followed by centrifugation at 16,000 x g 
and washing of the pellet twice with 10% TCA.  The amount of radioactivity in the pellet 
was measured using a γ-counter (LKB-Wallac RiaGamma 1274).  The protein 
concentration was determined using the Bradford method (Bio-Rad), and the specific 
activity (SA) in cpm/µg was then calculated and used for surface density (SD) 
determinations. 
Cover slips (15 mm diameter) were used to determine adsorption onto glass.  The 
discs were incubated with the 125I-labeled protein, diluted 1:100 in unlabeled protein, and 
incubated at 4ºC for 24 hours.  The discs were then blocked with 1% BSA in PBS at 
room temperature for 45 minutes, and then washed with PBS.  The adsorbed radioactivity 
of each disc was determined using a γ-counter.  The protein concentration vs. SD was 











A.1.3 Glass Microsphere Adhesion Assay 
Cell-substrate adhesive strength was determined by employing a modified 
centrifugation assay.  Briefly, human plasma FN was pre-adsorbed onto 30-50 µm (mean 
diameter = 38.5 µm) glass microspheres (Polysciences, Warrington, PA) by incubating 
them in 100 µg/mL of the protein at 4ºC for at least 24 hours.  The microspheres were 
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then washed five times with PBS, blocked with 1% BSA in PBS for 45 minutes at room 
temperature, and washed three more times in PBS.  At this point, the microspheres were 
suspended in serum-free medium (MCDB 104 Medium, Gibco BRL) supplemented with 
Supplement-X (10 mg/L insulin, 5.5 mg/L transferrin, 6.7 µg/mL sodium-selenite; Gibco 
BRL), 2 mM L-glutamine (Mediatech), 1 mM CaCl2 and Penicillin/Streptomycin.  PAC-
1 cells were sub-cultured at an initial density of 3x105 cells/mL into each of the 72 inner 
wells of a 96-well culture-treated strip plate (Corning) and cultured in growth medium 
until 80% confluent (approximately 4 days).  The cells were then quiesced for 24 hours, 
rinsed twice with PBS, and 200 µL of the microsphere suspension was placed in each 
well on top of the cell monolayer.  The cells were incubated for 6 to 8 hours at 37ºC, after 
which the strip wells were detached in sets of two, placed inverted into a 12-well plate, 
filled with 0.01% BSA in PBS.  Each plate was placed in a swing-bucket holder and 
centrifuged (Thermo EC), at designated speeds ranging from 500-3400 rpm 
(approximately 50-2500 x g) for one minute from the time maximum angular velocity 
was reached.   
In this assay a range of detachment forces was applied to a population of matrix-
coated glass microspheres, and the quantity of beads that adhered to the monolayer of 
cells upon inversion of the culture dish varied in a time-dependent manner.  In plotting 
the percentage of adherent microspheres vs. the relative centrifugal force (RCF), the force 
value at which 50% of the microspheres detached could be determined and was 
designated as RCF50.   For example, the RCF50 was approximately 500 ± 100 x g for FN-
coated glass microspheres that had been deposited and incubated for 6 hours on a 
monolayer of PAC-1 cells. 
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Different samples were centrifuged for 1 minute in increments of 500 rpm.  Each 
well was then viewed at 40X magnification using an inverted microscope (Nikon) with 
ambient visible light illumination.  The reflection of the rounded microspheres provided 
adequate contrast with low background noise, and enabled precise image measurements.  
Since the area covered by the microspheres was proportional to the total number attached 
to the cells, the fraction of glass microspheres remaining was determined by measuring 
the covered area, using IP Lab Spectrum image analysis software (Scanalytics).  The 
results were fit to the following symmetrical logistic model (Equation 2.2), using the 
Marquardt-Levenberg algorithm, where f is the percent adherent glass microspheres, f0 is 
the percent adherent at zero force, b is the decay slope, and RCF was measured in 
gravitational units, g.  The parameters b and RCF50 were then calculated: 
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A.2 Mathematical Modeling of the Adhesion Assay 
To calculate the actual negative pressure, or normal force per unit area, applied to 
the cells during the bead removal process, several assumptions were made.  In order to 
determine the contact area between the cells and the microspheres, spread cells were 
modeled as a slab of uniform thickness.  Due to the presence of the nucleus and 
lamellipods, the uniform thickness assumption may not be completely accurate.  
However, the mean thickness of the spots encountered by the beads should be 
approximately the mean thickness of the cell.  To determine the mean thickness, we 
assumed that the volume of the cells remain constant whether the cell is detached and 
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rounded or attached and spread.  Further, we used a spherical model for detached and 
rounded cells in calculating its volume.  Digital images of cells that are attached and 
spread as well those that are detached and rounded were captured using a CCD video 
camera.  The pixel size was calibrated with a stage micrometer and the area of the cells 
was then calculated using simple image analysis techniques.  The mean thickness of the 






πδ =  (A.3) 
 
where δ is the thickness of the slab, r is the mean radius of the detached cells calculated 
from the area determined from the image analysis, and A is the mean area of the attached 
and spread cells.   
The surface area of the microsphere in contact with the cells is dependent on how 
deeply the microsphere sinks into the cell (Figure 34).  This depth would range between 
the two extremes: the maximum depth into which the microsphere may sink, i.e., the 
mean thickness of the cell δ, and the minimum, or zero.  The maximum would occur if 
the bead sank all the way through the cell and came in contact with the bottom of the well, 
or, more realistically, if the microsphere came to rest in the valley between two adjacent 
cells.  The minimum contact model is highly unlikely, since it requires that the cells be 
treated as hard objects with zero deformation, thus modeling the interface between the 
cell and the microsphere as a point contact.  Given the relatively high density of the 
microspheres, the pliability of the cells, and the size of the beads, we chose to use the 
maximum depth model in calculating the contact surface area. 
The amount of normal force applied to the cell surface by the beads during the 
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centrifugation process can be calculated by 
 
 ( )F V RCFρ= ∆  (A.4) 
 
where F is the force, V is the volume of the microsphere, ρ∆ is the difference in density 
between the media and the glass beads, and RCF is the relative centrifugal force.  
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where D is the mean diameter of the microspheres.  The negative pressure applied on the 
cell by the beads during the centrifugation process is simply the force divided by the 
contact area, or 
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where P is the pressure pulling away from the cell surface, and δ is the thickness of the 
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where RCF is expressed in g's (9.81 m/s2).  In other words, for every gravitational unit of 
acceleration applied to the system, the cells experience 133 µN/cm2 of negative pressure 
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Figure 34. Minimum (A) and maximum (B) contact models of glass microspheres on 
a confluent layer of vascular smooth muscle cells.  The mean thickness of the smooth 
muscle cells is calculated by dividing the mean volume of the detached cells by the mean 












Figure 35. Glass microspheres seeded on PAC1 layer, as visualized at 100X 
magnification with only ambient light.  The microspheres were coated with 100 µg/mL 
FN overnight and incubated on the cell layer for 1 hour (A) or 8 hours (B) before they 
were removed by inverting the wells.  With a 1 hour incubation, approximately 5% of the 








SUPPLEMENTAL DATA TO CHAPTER 4 
 
The syndecan-1 and syndecan-2 gene expression data yielded results which 
focused our interest on the regulation of cell-associated protein and shedding, in 
comparison with syndecan-4.  Preliminary results were obtained, and are presented below. 
 
B.1 Materials and Methods 
B.1.1 Cell Culture 
Clonetics normal human aortic SMCs, culture medium and supplements were 
obtained from Cambrex Bio Science, and the cells were sub-cultured using standard 
techniques.  SmGM-2 was prepared according to the supplier’s recommendations 
(SmBM, supplemented with 5% FBS, 500 µg/mL hEGF, 5 µg/mL insulin, 2 mg/mL 
hFGF, 50 µg/mL gentamycin, and 50 mg/mL amphotericin-B.  Cells were maintained in 
tissue culture-treated petri dishes at 37ºC, 5% CO2, and humidified atmosphere.  Growth 
medium was changed every two days, and the cells were passaged 1:4 when the dishes 
were 80% confluent, using 0.05% Trypsin / 0.53 mM EDTA.  Experiments were 
performed on cells between passages 6 and 10 using Quiescence medium, which 
consisted of SmBM supplemented with 0.5% FBS, 50 µg/mL gentamycin, and 50 mg/mL 
amphotericin-B. 
 
B.1.2 Mechanical Strain Application 
Strain dishes were assembled in the following manner: the bases of bottomless, 
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custom-made plastic petri dishes were fitted with silicone membrane (0.5 inch thickness; 
40 Durometer).  The silicone served as a flexible growth area of the strain dishes.  For all 
experiments, 5 µg/mL human plasma FN in PBS was pre-adsorbed to the growth area for 
at least 8 hours at 4ºC, serving as a substrate for cell attachment.  The cells were then 
seeded onto the membranes, cultured to 80% confluence in SmGM-2, and then growth-
arrested for 24 hours in Quiescence medium.   
Depending on the experimental conditions, defined static or cyclic tension was 
applied to the cells using a StrainMaster apparatus.  Contacting surfaces of the membrane 
and strain device were lubricated with Dawn concentrated dishwashing liquid.  Static and 
cyclic tensions were applied using a StrainMaster apparatus that allowed control over the 
frequency and amplitude of the radial and circumferential strains of the membrane and, 
and enabled the application of homogeneous and biaxially uniform strains over the entire 
growth area of the membrane. 
The protocol for the application of mechanical strain for subsequent protein 
analysis was slightly different than for the RNA analysis.  Following MAP kinase 
inhibitor pre-treatment (when appropriate), stretching (1 Hz, 10% cyclic strain) of the 
various samples commenced in a staggered fashion, based upon the total duration that 
each was to be strained (Figure 21).  Since all samples were harvested simultaneously, 
stretching of the 24 hour strain samples commenced immediately, whereas stretching of 
the 4  and 1 hour strain samples were commenced at t = 20 hours and 23 hours, 
respectively.  Non-stretched controls were performed concurrently for all experiments. 
 
B.1.3 Shed Proteoglycan Isolation and Quantification 
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The following protocols were adapted from Reiland et al.221 and Rioux et al.222.  
After the cells were treated with one of the strain protocols, the conditioned medium was 
passed through a 0.2 µM membrane filter (Millipore, Billerica, MA) in order to remove 
detached cells and debris.  For shed syndecan-1 and syndecan-2 purification urea and 
NaOAc were added to bring the final concentrations to 2 M and 50 mM, respectively.  
The pH was then adjusted to 4.5 with acetic acid.  The conditioned medium was 
incubated with pre-equilibrated DEAE Sepharose fast flow beads (Sigma-Aldrich) 
overnight at 4ºC with gentle agitation.  Following incubation, the beads were washed 
three times with PBS and the proteoglycans were eluted with 10 mL of 1 M NaCl in PBS.  
The medium was concentrated to 1 mL using a 10,000 MWCO Amicon Ultra-15 
Centrifugal Filter Unit (Millipore).  Total protein was quantified using the BCA method 
(Pierce Biotechnology, Rockford, IL).  GAG chains were digested by adding 250 ng 
protein to a 70 µL reaction containing 10 mM Tris-HCl pH 7.4, 150 mM NaCl, 4 mM 
CaCl2, and 5 mU heparitinase (F. heparinum, EC 4.2.2.8, Seikagaku America, East 
Falmouth, MA) for 16 hours at 37ºC, after which an equal volume of Laemmli sample 
buffer containing 5% β-mercaptoethanol was added to each reaction.  The samples were 
then ready for analysis.  
The conditioned medium samples were resolved by SDS-PAGE, and then were 
transferred to a 0.45 µm Nytran SPC membrane (Schleicher & Schuell, Keene, NH).  The 
membrane was blocked for 1 hour at room temperature in 3% nonfat dry milk / 0.5% 
BSA in PBS, followed by a 30 minute incubation in the same blocking solution with the 
addition of 0.3% Tween 20.  The immunoblots were labeled overnight at 4ºC with anti-
syndecan-1 mAb (Accurate Chemical & Scientific, Westbury, NY) or with anti-
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syndecan-2 Ab (Santa Cruz Biotechnology, Santa Cruz, CA), both diluted 1:200 in 
blocking buffer.  They were then washed in 0.5% Igepal CA-630 (Sigma-Aldrich) in TBS 
pH 7.4, followed by incubation with horseradish peroxidase anti-mouse or rabbit IgG 
(Bio-Rad) diluted 1:5000 in blocking buffer for 1 hour.  The immunoblot was developed 
using enhanced chemiluminescence (Amersham), and the labeled protein was detected 
using BioMax MR autoradiography film.  Levels of protein were quantified by 
densitometry using ONE-Dscan image analysis software. 
 
B.1.4 Cell-Associated Proteoglycan Isolation and Quantification 
For cell-associated syndecan-1 and syndecan-2 purification, the cells were washed 
twice with cold PBS, and 500 µL of lysis buffer was added to them, containing 20 mM 
Tris-HCl pH 7.4, 150 µM NaCl, 10 mM EDTA, 1% Triton X-100, and protease inhibitors.  
Following a 15 minute incubation on ice, the cells were scraped from the plates and 
homogenized by passing several times through a 26G needle.  The cell lysates were 
centrifuged at 16,000 x g for 15 min at 4ºC.  The supernatants were kept for analysis.  As 
with the conditioned medium, total protein was quantified, but 5 µg of total protein was 
used in each heparitinase reaction.  GAG chains were digested in a 70 µL heparitinase 
reaction, containing the same components as the conditioned medium, for 16 hours at 
37ºC, after which an equal volume of Laemmli sample buffer containing 5% β-
mercaptoethanol was added.  The samples were then ready for analysis by SDS-PAGE in 
the same manner as the shed syndecan-1 and syndecan-2 samples. 
 
B.1.5 Statistics and Data Analysis 
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Values are given as mean ± SEM.  Statistical analysis was performed using 
SigmaStat  3.0 software package.  ANOVA was employed, using the Holm-Sidak or 
Tukey tests for multiple pairwise comparisons among the treatments.  When applicable, 
logarithmic transformation of the data was necessary prior to statistical analysis in order 
for it to conform to the ANOVA assumptions.  A p value < 0.05 was considered 
statistically significant for all tests. 
 
B.2 Results 
B.2.1 Cyclic Strain Regulates Shed and Cell-Associated Syndecan Protein 
The StrainMaster device was again used to mechanically strain cells in order to 
gain insight into the influence of mechanical strain on syndecan regulation.  For these 
experiments, the strain protocol we chose to employ was 10% cyclic strain, 1 Hz, for 
various periods of time.  The promising gene expression data for this strain regime 
suggested it as an appropriate initial target.  The availability of successful experimental 
conditions for syndecan-4 dictated a more in-depth analysis of that protein’s regulation 
than for syndecan-1 and syndecan-2.  However, preliminary studies are represented in 
Figure 36 and Figure 37.  Western immunoblots of conditioned medium from cells 
strained for 0 and 24 hours, and of lysates from cells strained for 0 and 48 hours revealed 
a faint 75 kD band corresponding to the heparitinase-digested syndecan-1 core protein 
(Figure 36A).  Shed syndecan-1 from cells strained for 24 hours at 10% cyclic strain was 
increased to 278% of the unstrained control cells (Figure 36B).  In contrast to this, 
syndecan-1 in the cell lysates of cells strained for 48 hours was reduced to 38%.  
Syndecan-2 was more readily detected by immunoblotting than syndecan-1, and revealed 
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a 45-50 kD band in both the shed and cell-associated fractions, corresponding to the 
heparitinase-digested syndecan-2 core protein (Figure 37A).  Similar to the regulation of 
syndecan-1, shed syndecan-2 from cells subjected to 10% cyclic strain increased to 113% 
of unstrained controls at 48 hours, while the cell-associated syndecan-2 decreased to 39% 
at 24 hours. 
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Figure 36. Immunoblot (A) and densitometry (B) analysis demonstrating syndecan-
1 protein expression in response to cyclic mechanical strain.  Human aortic SMCs 
were cultured on elastic membranes and stretched for the indicated periods of time.  Cell-
associated (■) or shed (■) protein was isolated and analyzed by Western blotting.  
Syndecan-1 protein levels are presented relative to unstrained controls.   
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Figure 37. Immunoblot (A) and densitometry (B) analysis demonstrating syndecan-
2 protein expression and shedding in response to cyclic mechanical strain.  Human 
aortic SMCs were cultured on elastic membranes and stretched for the indicated periods 
of time.  Cell-associated (■) or shed (■) protein was isolated and analyzed by Western 
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